[Federal Register Volume 72, Number 60 (Thursday, March 29, 2007)]
[Rules and Regulations]
[Pages 14681-14708]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E7-5797]


-----------------------------------------------------------------------

ENVIRONMENTAL PROTECTION AGENCY

40 CFR Part 721

[EPA-HQ-OPPT-2003-0063; FRL-7699-5]
RIN 2070-AB27


Significant New Use Rules on Certain Chemical Substances and 
Notification on Certain Substances for Which Significant New Use Rules 
are Not Being Issued

AGENCY: Environmental Protection Agency (EPA).

ACTION: Direct final rule.

-----------------------------------------------------------------------

SUMMARY: EPA is promulgating significant new use rules (SNURs) under 
section 5(a)(2) of the Toxic Substances Control Act (TSCA) for 65 
chemical substances which were the subject of premanufacture notices 
(PMNs). Thirteen of these chemical substances are subject to TSCA 
section 5(e) consent orders issued by EPA. This action requires persons 
who intend to manufacture, import, or process any of these 65 chemical 
substances for an activity that is designated as a significant new use 
by this rule to notify

[[Page 14682]]

EPA at least 90 days before commencing that activity. The required 
notification will provide EPA with the opportunity to evaluate the 
intended use and, if necessary, to prohibit or limit that activity 
before it occurs. This direct final rule also provides notification on 
two substances for which EPA has decided not to issue significant new 
use rules at this time.

DATES: The effective date of this rule is May 29, 2007 without further 
notice, unless EPA receives adverse or critical comments, or notice of 
intent to submit adverse or critical comments before April 30, 2007. 
This rule shall be promulgated for purposes of judicial review at 1 
p.m. (e.s.t.) on April 12, 2007.
    If EPA receives adverse or critical comments, or notice of intent 
to submit adverse or critical comments, on one or more of these SNURs 
before April 30, 2007, EPA will withdraw the relevant sections of this 
direct final rule before its effective date. EPA will then issue a 
proposed SNUR for the chemical substance(s) on which adverse or 
critical comments were received, providing a 30-day period for public 
comment.

ADDRESSES: Submit your comments, identified by docket identification 
(ID) number EPA-HQ-OPPT-2003-0063, by one of the following methods:
    <bullet> Federal eRulemaking Portal: http://www.regulations.gov. 
Follow the on-line instructions for submitting comments.
    <bullet> Mail: Document Control Office (7407M), Office of Pollution 
Prevention and Toxics (OPPT), Environmental Protection Agency, 1200 
Pennsylvania Ave., NW., Washington, DC 20460-0001.
    <bullet> Hand Delivery: OPPT Document Control Office (DCO), EPA 
East Bldg., Rm. 6428, 1201 Constitution Ave., NW., Washington, DC. 
Attention: Docket ID number EPA-HQ-OPPT-2003-0063. The DCO is open from 
8 a.m. to 4 p.m., Monday through Friday, excluding legal holidays. The 
telephone number for the DCO is (202) 564-8930. Such deliveries are 
only accepted during the DCO's normal hours of operation, and special 
arrangements should be made for deliveries of boxed information.
    Instructions: Direct your comments to docket ID number EPA-HQ-OPPT-
2003-0063. EPA's policy is that all comments received will be included 
in the public docket without change and may be made available on-line 
at http://www.regulations.gov, including any personal information 
provided, unless the comment includes information claimed to be 
Confidential Business Information (CBI) or other information whose 
disclosure is restricted by statute. Do not submit information that you 
consider to be CBI or otherwise protected through regulations.gov or e-
mail. The regulations.gov website is an ``anonymous access'' system, 
which means EPA will not know your identity or contact information 
unless you provide it in the body of your comment. If you send an e-
mail comment directly to EPA without going through regulations.gov, 
your e-mail address will be automatically captured and included as part 
of the comment that is placed in the public docket and made available 
on the Internet. If you submit an electronic comment, EPA recommends 
that you include your name and other contact information in the body of 
your comment and with any disk or CD ROM you submit. If EPA cannot read 
your comment due to technical difficulties and cannot contact you for 
clarification, EPA may not be able to consider your comment. Electronic 
files should avoid the use of special characters, any form of 
encryption, and be free of any defects or viruses. For additional 
information about EPA's public docket visit the EPA Docket Center 
homepage at http://www.epa.gov/epahome/dockets.htm.
    Docket: All documents in the docket are listed in the docket's 
index available at http://www.regulations.gov. Although listed in the 
index, some information is not publicly available, e.g., CBI or other 
information whose disclosure is restricted by statute. Certain other 
material, such as copyrighted material, will be publicly available only 
in hard copy. Publicly available docket materials are available 
electronically at http://www.regulations.gov, or, if only available in 
hard copy, at the OPPT Docket. The OPPT Docket is located in the EPA 
Docket Center (EPA/DC) at Rm. 3334, EPA West Bldg., 1301 Constitution 
Ave., NW., Washington, DC. The EPA/DC Public Reading Room hours of 
operation are 8:30 a.m. to 4:30 p.m., Monday through Friday, excluding 
Federal holidays. The telephone number of the EPA/DC Public Reading 
Room is (202) 566-1744, and the telephone number for the OPPT Docket is 
(202) 566-0280. Docket visitors are required to show photographic 
identification, pass through a metal detector, and sign the EPA visitor 
log. All visitor bags are processed through an X-ray machine and 
subject to search. Visitors will be provided an EPA/DC badge that must 
be visible at all times in the building and returned upon departure.

FOR FURTHER INFORMATION CONTACT: For general information contact: Colby 
Lintner, Regulatory Coordinator, Environmental Assistance Division 
(7408M), Office of Pollution Prevention and Toxics, Environmental 
Protection Agency, 1200 Pennsylvania Ave., NW., Washington, DC 20460-
0001; telephone number: (202) 554-1404; e-mail address: <a href="/cdn-cgi/l/email-protection#42161101036f0a2d362e2b2c27022732236c252d34"><span class="__cf_email__" data-cfemail="85d1d6c6c4a8cdeaf1e9ecebe0c5e0f5e4abe2eaf3">[email protected]</span></a>.
    For technical information contact: Karen Chu, Chemical Control 
Division (7405M), Office of Pollution Prevention and Toxics, 
Environmental Protection Agency, 1200 Pennsylvania Ave., NW., 
Washington, DC 20460-0001; telephone number: (202) 564-8773; e-mail 
address: <a href="/cdn-cgi/l/email-protection#d4b7bca1fabfb5a6b1ba94b1a4b5fab3bba2"><span class="__cf_email__" data-cfemail="e3808b96cd888291868da3869382cd848c95">[email protected]</span></a>.

SUPPLEMENTARY INFORMATION:

I. General Information

A. Does this Action Apply to Me?

    You may be potentially affected by this action if you manufacture, 
import, process, or use the chemical substances contained in this rule. 
Potentially affected entities may include, but are not limited to:
    <bullet> Manufacturers, importers, or processors of one or more 
subject chemical substances (NAICS codes 325 and 324110), e.g., 
Chemical manufacturing and petroleum refineries.
    This listing is not intended to be exhaustive, but rather provides 
a guide for readers regarding entities likely to be affected by this 
action. Other types of entities not listed in this unit could also be 
affected. The North American Industrial Classification System (NAICS) 
codes have been provided to assist you and others in determining 
whether this action might apply to certain entities. To determine 
whether you or your business may be affected by this action, you should 
carefully examine the applicability provisions in 40 CFR 721.5. If you 
have any questions regarding the applicability of this action to a 
particular entity, consult the technical person listed under FOR 
FURTHER INFORMATION CONTACT.
    This action may also affect certain entities through pre-existing 
import certification and export notification rules under TSCA. Persons 
who import any chemical substance governed by a final SNUR are subject 
to the TSCA section 13 (15 U.S.C. 2612) import certification 
requirements and the corresponding regulations at 19 CFR 12.118 through 
12.127 and 19 CFR 127.28. Those persons must certify that the shipment 
of the chemical substance complies with all applicable rules and orders 
under TSCA, including any SNUR requirements. The EPA policy in support 
of import certification appears at 40 CFR part 707, subpart B. In 
addition, any persons who export or intend to export a chemical 
substance

[[Page 14683]]

that is the subject of this rule on or after April 30, 2007 are subject 
to the export notification provisions of TSCA section 12(b) (15 U.S.C. 
2611(b)) (see 40 CFR 721.20), and must comply with the export 
notification requirements in 40 CFR part 707, subpart D.

B. What Should I Consider as I Prepare My Comments for EPA?

    1. Submitting CBI. Do not submit this information to EPA through 
regulations.gov or e-mail. Clearly mark the part or all of the 
information that you claim to be CBI. For CBI information in a disk or 
CD ROM that you mail to EPA, mark the outside of the disk or CD ROM as 
CBI and then identify electronically within the disk or CD ROM the 
specific information that is claimed as CBI. In addition to one 
complete version of the comment that includes information claimed as 
CBI, a copy of the comment that does not contain the information 
claimed as CBI must be submitted for inclusion in the public docket. 
Information so marked will not be disclosed except in accordance with 
procedures set forth in 40 CFR part 2.
    2. Tips for preparing your comments. When submitting comments, 
remember to:
    i. Identify the document by docket ID number and other identifying 
information (subject heading, Federal Register date, and page number).
    ii. Follow directions. The Agency may ask you to respond to 
specific questions or organize comments by referencing a Code of 
Federal Regulations (CFR) part or section number.
    iii. Explain why you agree or disagree; suggest alternatives and 
substitute language for your requested changes.
    iv. Describe any assumptions and provide any technical information 
and/or data that you used.
    v. If you estimate potential costs or burdens, explain how you 
arrived at your estimate in sufficient detail to allow for it to be 
reproduced.
    vi. Provide specific examples to illustrate your concerns and 
suggest alternatives.
    vii. Explain your views as clearly as possible, avoiding the use of 
profanity or personal threats.
    viii. Make sure to submit your comments by the comment period 
deadline identified.

II. Background

A. What Action is the Agency Taking?

    EPA is promulgating these SNURs using direct final procedures. 
These SNURs will require persons to notify EPA at least 90 days before 
commencing the manufacture, import, or processing of a chemical 
substance for any activity designated by these SNURs as a significant 
new use. Additional rationale and background to this rule are more 
fully set out in the preamble to EPA's first direct final SNUR 
published in the Federal Register of April 24, 1990 (55 FR 17376). 
Consult that preamble for further information on the objectives, 
rationale, and procedures for SNURs and on the basis for significant 
new use designations, including provisions for developing test data.

B. What is the Agency's Authority for Taking this Action?

    Section 5(a)(2) of TSCA (15 U.S.C. 2604(a)(2)) authorizes EPA to 
determine that a use of a chemical substance is a ``significant new 
use.'' EPA must make this determination by rule after considering all 
relevant factors, including those listed in TSCA section 5(a)(2). Once 
EPA determines that a use of a chemical substance is a significant new 
use, TSCA section 5(a)(1)(B) requires persons to submit a significant 
new use notice (SNUN) to EPA at least 90 days before they manufacture, 
import, or process the chemical substance for that use. The mechanism 
for reporting under this requirement is established under 40 CFR part 
721.5.

C. Applicability of General Provisions

    General provisions for SNURs appear under 40 CFR part 721, subpart 
A. These provisions describe persons subject to the rule, recordkeeping 
requirements, exemptions to reporting requirements, and applicability 
of the rule to uses occurring before the effective date of the final 
rule. Provisions relating to user fees appear at 40 CFR part 700. 
According to 40 CFR 721.1(c), persons subject to these SNURs must 
comply with the same notice requirements and EPA regulatory procedures 
as submitters of PMNs under TSCA section 5(a)(1)(A). In particular, 
these requirements include the information submission requirements of 
TSCA section 5(b) and 5(d)(1), the exemptions authorized by TSCA 
section 5 (h)(1), (h)(2), (h)(3), and (h)(5), and the regulations at 40 
CFR part 720. Once EPA receives a SNUN, EPA may take regulatory action 
under TSCA section 5(e), 5(f), 6, or 7 to control the activities on 
which it has received the SNUN. If EPA does not take action, the Agency 
is required under TSCA section 5(g) to explain in the Federal Register 
its reasons for not taking action.
    Persons who export or intend to export a chemical substance 
identified in a proposed or final SNUR are subject to the export 
notification provisions of TSCA section 12(b). The regulations that 
interpret TSCA section 12(b) appear at 40 CFR part 707, subpart D. 
Persons who import a chemical substance identified in a final SNUR are 
subject to the TSCA section 13 import certification requirements, 
codified at 19 CFR 12.118 through 12.127 and 19 CFR 127.28. Such 
persons must certify that the shipment of the chemical substance 
complies with all applicable rules and orders under TSCA, including any 
SNUR requirements. The EPA policy on import certification appears at 40 
CFR part 707, subpart B.

III. Substances Subject to this Rule

    EPA is establishing significant new use and recordkeeping 
requirements for 65 chemical substances under 40 CFR part 721, subpart 
E. In this unit, EPA provides the following information for each 
chemical substance:
    <bullet> PMN number.
    <bullet> Chemical name (generic name if the specific name is 
claimed as CBI).
    <bullet> CAS number (if assigned for non-confidential chemical 
identities).
    <bullet> Basis for the section 5(e) consent order, or, for non-5(e) 
SNURs, the basis for the SNUR.
    <bullet> Toxicity concerns.
    <bullet> Tests recommended by EPA to provide sufficient information 
to evaluate the chemical substance (see Unit VI. for more information).
    <bullet> CFR citation assigned in the regulatory text section of 
this rule.
    The specific activities designated as significant new uses are 
listed in the regulatory text section of 40 CFR part 721, subpart E. 
Certain new uses, including production limits and other uses designated 
in the rule are claimed as CBI. The procedure for obtaining 
confidential information is set out in Unit VII.
    This rule includes SNURs on 13 PMN substances that are subject to 
``risk-based'' consent orders under TSCA section 5(e)(1)(A)(ii)(I) 
wherein EPA determined that activities associated with the PMN 
substances may present unreasonable risk to health or the environment. 
The consent orders require protective measures to limit exposures or 
otherwise mitigate the potential unreasonable risk. The so-called 
``5(e) SNURs'' on these substances are promulgated pursuant to 40 CFR 
721.160, and are based on and consistent with the provisions in the 
underlying consent orders. The SNURs designate as a ``significant new 
use'' the absence of the protective measures required in the consent 
order.
    Where EPA determined that the PMN substance may present an 
unreasonable risk of injury to human health via

[[Page 14684]]

inhalation exposure, the underlying section 5(e) consent order usually 
requires, among other things, that potentially exposed employees must 
wear specified respirators unless actual measurements of the workplace 
air show that air-borne concentrations of the PMN substance are below a 
New Chemical Exposure Limit (NCEL) that is established by EPA to 
provide adequate protection to human health. In addition to the actual 
NCEL concentration, the comprehensive NCELs provisions in section 5(e) 
consent orders, which are modeled after Occupational Safety and Health 
Administration (OSHA) Permissible Exposure Limits (PELs) provisions, 
include requirements addressing performance criteria for sampling and 
analytical methods, periodic monitoring, respiratory protection, and 
recordkeeping. However, no comparable NCELs provisions currently exist 
in 40 CFR part 721, subpart B for SNURs. Therefore, for these cases, 
the individual SNURs in subpart E state that persons subject to the 
SNUR who wish to pursue NCELs as an alternative to the Sec.  721.63 
respirator requirements may request to do so under 40 CFR 721.30. 
Persons whose Sec.  721.30 requests to use the NCELs approach are 
approved by EPA will receive NCELs provisions comparable to those 
contained in the corresponding section 5(e) consent order for the same 
chemical substance for SNURs.
    This rule also includes SNURs on 52 PMN substances that are not 
subject to consent orders under TSCA section 5(e). In these cases, EPA 
did not find that the use scenario described in the PMN triggered the 
determinations set forth under section 5(e) of TSCA. EPA, however, does 
believe that certain changes from the use scenario described in the PMN 
could result in increased exposures, thereby constituting a 
``significant new use.'' These so called ``Non-5(e) SNURs'' are 
promulgated pursuant to 40 CFR 721.170. EPA has determined that every 
activity designated as a ``significant new use'' in all non-5(e) SNURs 
issued under 40 CFR 721.170 satisfies the two requirements stipulated 
in Sec.  721.170(c)(2), i.e., these significant new use activities, 
``(i) are different from those described in the premanufacture notice 
for the substance, including any amendments, deletions, and additions 
of activities to the premanufacture notice, and (ii) may be accompanied 
by changes in exposure or release levels that are significant in 
relation to the health or environmental concerns identified'' for the 
PMN substance.
PMN Number P-97-415
Chemical name: 2-Thiazolidinone.
CAS number: 2682-49-7.
Effective date of section 5(e) consent order: April 20, 2000.
Basis for section 5(e) consent order: The PMN states that the substance 
will be used as an intermediate. The order was issued under section 
5(e)(1)(A)(i) and (ii)(I) of TSCA based on a finding that this 
substance may present an unreasonable risk of injury to health and the 
environment. To protect against this risk, the consent order requires 
worker protection and hazard communication and restricts disposal, 
water releases, and aggregate manufacture/importation volume of the PMN 
substance. It also prohibits use of the PMN substance other than as an 
intermediate and prohibits domestic manufacturing, processing, or use 
of the PMN substance as a powder. The SNUR designates as a `significant 
new use' the absence of these protective measures.
Toxicity concern: EPA has identified health concerns for high acute 
toxicity and signs of neurotoxic effects based on test data for the PMN 
substance. EPA also has concerns for chronic effects and systemic, 
developmental, and maternal toxicity based on test data on a 
structurally similar substance. The NCEL is 0.7 mg/m\3\ as an 8-hour 
time-weighted average. EPA is concerned that toxicity to aquatic 
organisms may occur at concentrations as low as 300 parts per billion 
(ppb) of the PMN substance in surface waters based on test data on a 
structurally similar substance.
Recommended testing: EPA has determined that the following test would 
help characterize the human health effects of the PMN substance: A 
combined repeated dose toxicity with the reproductive/developmental 
toxicity screening test (oral route) (OPPTS 870.3650 test guideline) 
with a neurotoxicity functional observational battery (National 
Technical Information Service (NTIS) PB 91-154617) and a 
histopathologic examination extended to include the blood, liver, 
kidney, brain, and spinal cord on the PMN substance to help 
characterize neurotoxic, systemic, reproductive, and developmental 
effects. The PMN submitter has agreed not to exceed the production 
volume limit without performing this test. In addition, EPA has 
determined that a porous pot test (OPPTS 835.3220 test guideline), a 
fish acute toxicity test (OPPTS 850.1075 test guideline (public 
draft)), a daphnid acute toxicity test (OPPTS 850.1010 test guideline 
(public draft)), and an algal toxicity test (OPPTS 850.5400 test 
guideline (public draft)) would help characterize the environmental 
effects of the PMN substance.
CFR citation: 40 CFR 721.10002.
PMN Numbers P-98-625/626/627/628/629 and P-00-614/617
Chemical name: Manganese heterocyclic tetraamine complex (generic).
CAS number: Not available.
Basis for action: The PMNs state that the generic (non-confidential) 
use of the substances will be in commercial research and development. 
EPA has identified health concerns for chronic organ effects based on 
data on a structurally similar substance. Since significant worker 
exposure is unlikely at the production volume identified in the PMNs, 
EPA has not determined that the proposed manufacture, processing, or 
use of the substances may present an unreasonable risk. EPA has 
determined, however, that a manufacture or importation volume greater 
than 10,000 kilograms/year of any one of the PMN substances may result 
in serious chronic effects. Based on this information, each of the PMN 
substances meet the concern criteria at Sec.  721.170(b)(3)(ii).
Recommended testing: EPA has determined that the results of a 90-day 
oral toxicity study (OPPTS 870.3100 test guideline) would help 
characterize the human health effects of the PMN substances.
CFR citation: 40 CFR 721.10003.
PMN Number P-98-1181
Chemical name: 2-Butenoic acid, 4,4'-
[(dibutylstannylene)bis(oxy)]bis[4-oxo-, (2Z,2'Z)-, di-
C<INF>8-10</INF>-isoalkyl esters, C<INF>9</INF>-rich.
CAS number: 247041-56-1.
Basis for action: The PMN states that the substance will be used as a 
polyvinyl chloride stabilizer. EPA has identified concerns for 
corrosion to skin, eyes, and mucuous membranes, neurotoxicity, blood 
toxicity, liver toxicity, immunosupression, reproductive toxicity, and 
adrenal effects based on analogy to organotins. As described in the 
PMN, significant worker exposure is unlikely. Therefore, EPA has not 
determined that the proposed manufacturing, processing, or use of the 
substance may present an unreasonable risk. EPA has determined, 
however, that uses of the substance in a solid form, involving an 
application method that generates a vapor, mist, or aerosol, or where 
there is potential dermal exposure without the use of impervious 
gloves, may cause serious health effects. Based on this information, 
the PMN substance meets the concern criteria at Sec.  
721.170(b)(3)(ii).
Recommended testing: EPA has determined that the results of a 90-day

[[Page 14685]]

oral toxicity study (OPPTS 870.3100 test guideline) and a neurotoxicity 
screening test (OPPTS 870.6200 test guideline) would help characterize 
the human health effects of the PMN substance.
CFR citation: 40 CFR 721.10004.
PMN Number P-98-1182
Chemical name: 2-Butenoic acid, 4,4'-
[(dibutylstannylene)bis(oxy)]bis[4-oxo-, (2Z,2'Z)-, di-
C<INF>9-11</INF>-isoalkyl esters, C<INF>10</INF>-rich.
CAS number: Not available.
Basis for action: The PMN states that the substance will be used as a 
polyvinyl chloride stabilizer. EPA has identified concerns for 
corrosion to skin, eyes, and mucuous membranes, neurotoxicity, blood 
toxicity, liver toxicity, immunosupression, reproductive toxicity, and 
adrenal effects based on analogy to organotins. As described in the 
PMN, significant worker exposure is unlikely. Therefore, EPA has not 
determined that the proposed manufacturing, processing, or use of the 
substance may present an unreasonable risk. EPA has determined, 
however, that uses of the substance in a solid form, involving an 
application method that generates a vapor, mist, or aerosol, or where 
there is potential dermal exposure without the use of impervious 
gloves, may cause serious health effects. Based on this information, 
the PMN substance meets the concern criteria at Sec.  
721.170(b)(3)(ii).
Recommended testing: EPA has determined that the results of a 90-day 
oral toxicity study (OPPTS 870.3100 test guideline) and a neurotoxicity 
screening test (OPPTS 870.6200 test guideline) would help characterize 
the human health effects of the PMN substance.
CFR citation: 40 CFR 721.10005.
PMN Number P-99-511
Chemical name: Mixed metal oxide (generic).
CAS number: Not available.
Basis for action: The PMN states that the substance will be used as an 
additive for coatings. Based on data for a similar substance, EPA has 
identified concerns for cancer, immunotoxicity, and lung toxicity. As 
described in the PMN, significant inhalation exposure is unlikely. 
Therefore, EPA has not determined that the proposed manufacturing, 
processing, or use of the substance may present an unreasonable risk. 
EPA has determined, however, that a manufacture/importation volume 
greater than 60,000 kilograms/year of the PMN substance may cause 
serious health effects. Based on this information, the PMN substance 
meets the concern criteria at Sec.  721.170 (b)(1)(i)(C) and 
(b)(3)(ii).
Recommended testing: EPA has determined that a bacterial reverse 
mutation test (OPPTS 870.5100 test guideline) and a mammalian 
erythrocyte micronucleus test (intraperitoneal route) (OPPTS 870.5395 
test guideline) with special attention to histopathology of the lung 
tissues and organs of the immune systems (spleen, thymus, bone marrow) 
would help characterize the human health effects of the PMN substance. 
If the results of the recommended tests indicate that the PMN substance 
has carcinogenic potential, a carcinogenicity study (OPPTS 870.4200 
test guideline) would help further characterize the health effects.
CFR citation: 40 CFR 721.10006.
PMN Number P-00-11
Chemical name: Alcohols, C<INF>12-14</INF> - secondary, ethoxylated 
propoxylated.
CAS number: 103331-86-8.
Basis for action: The PMN states that the generic (non-confidential) 
use of the substance will be as a household cleaning agent additive. 
Based on analogy to nonionic surfactants, EPA is concerned that 
toxicity to aquatic organisms may occur at concentrations above 50 ppb 
in surface waters. As described in the PMN, releases of the substance 
are not expected to result in surface water concentrations above 50 
ppb. Thus, EPA has not determined that the proposed manufacturing, 
processing, or use of the substance may present an unreasonable risk. 
EPA has determined, however, that other uses of the substance resulting 
in surface water concentrations above 50 ppb may cause significant 
adverse environmental effects. Based on this information, the PMN 
substance meets the concern criteria at Sec.  721.170(b)(4)(ii).
Recommended testing: EPA has determined that a fish acute toxicity test 
(OPPTS 850.1075 test guideline (public draft)), a daphnid acute 
toxicity test (OPPTS 850.1010 test guideline (public draft)), and an 
algal toxicity test (OPPTS 850.5400 test guideline (public draft)) 
would help characterize the environmental effects of the PMN substance.
CFR citation: 40 CFR 721.10007.
PMN Numbers P-00-1121/1122/1123/1124/1125/1126
Chemical names: (P-00-1121) Manganese strontium oxide 
(MnSrO<INF>3</INF>); (P-00-1122) Manganese yttrium oxide 
(MnYO<INF>3</INF>); (P-00-1123) Barium manganese oxide 
(BaMnO<INF>3</INF>); (P-00-1124) Barium calcium manganese strontium 
oxide; (P-00-1125) Manganate (MnO<INF>2</INF>\1\<SUP>-</SUP>), calcium 
(2:1); and (P-00-1126) Manganese yttrium oxide 
(Mn<INF>2</INF>YO<INF>5</INF>).
CAS numbers: (P-00-1121) 12163-45-0, (P-00-1122) 12032-75-6, (P-00-
1123) 12230-80-7, (P-00-1124) 359427-90-0, (P-00-1125) 12049-47-7, and 
(P-00-1126) 12438-71-0.
Effective date of section 5(e) consent order: March 23, 2001.
Basis for section 5(e) consent order: The PMNs state that the generic 
(non-confidential) use of the substances will be as pigments. The order 
was issued under section 5(e)(1)(A)(i) and (e)(1)(A)(ii)(I) of TSCA 
based on a finding that these substances may present an unreasonable 
risk of injury to human health and the environment. To protect against 
this risk, the consent order requires hazard communication and 
restricts aggregate manufacture/importation volume, particle size and 
water releases of the PMN substances. The SNUR designates as a 
`significant new use' the absence of these protective measures.
Toxicity concern: EPA has health concerns for neurotoxicity and 
mutagenicity for the PMN substances based on exposure to manganese; 
concerns for lung toxicity, fibrosis, and possible cancer of the lungs 
due to potential exposure to the particulate form of the substances; 
and concern for lung effects through lung overload if respirable 
particles are inhaled. Based on test data on structurally similar 
substances, EPA is concerned that toxicity to aquatic organisms for 
each of these PMN substances may occur at concentrations as low as 100 
ppb in surface waters. Further, the Agency has determined that the PMN 
substances may be persistant, bioaccumulative, and toxic based on 
physical/chemical properties of the substances, consistent with the New 
Chemical Program's Persistant, Bioaccumulative, and Toxic (PBT) 
Category (64 FR 60194, November 4, 1999) (FRL-6097-7). Because of the 
potential PBT nature of the PMN substances, bioaccumulation and the 
potential for eventual exposure to humans and wildlife could result 
from exposure to concentrations below 100 ppb. Therefore, to adequately 
mitigate this concern, EPA has decided to limit surface water 
concentrations resulting from manufacturing, processing, or use to 1 
ppb or less for each of the PMN substances.
Recommended testing: EPA has determined that a fish bioconcentration 
factor (BCF) test (OPPTS 850.1730 test guideline (public draft)) would 
help characterize the environmental effects of the substances. The PMN 
submitter has

[[Page 14686]]

agreed not to exceed the production volume limit without performing the 
fish BCF test on P-00-1122 or P-00-1126. EPA has determined that a 90-
day inhalation toxicity study in rats with a 60-day holding period with 
special attention to the histopathology of the lungs (OPPTS 870.3465 
test guideline) would help characterize the human health effects of the 
PMN substances. Based on the results of the 90-day study, a 2-year 
inhalation carcinogenicity test (OPPTS 870.4200 test guideline) may be 
warranted.
CFR citations: 40 CFR 721.10008 (P-00-1121); 40 CFR 721.10009 (P-00-
1122); 40 CFR 721.10010 (P-00-1123); 40 CFR 721.10011 (P-00-1124); 40 
CFR 721.10012 (P-00-1125); and 40 CFR 721.10013 (P-00-1126).
PMN Number P-01-109
Chemical name: Halogenated naphthalic anhydride (generic).
CAS number: Not available.
Basis for action: The PMN states that the substance will be used as a 
dye intermediate. Based on toxicity data on structurally similar 
chemicals, EPA expects toxicity to aquatic organisms to occur at 
concentrations as low as 20 ppb of the PMN substance in surface waters. 
As described in the PMN, the substance is not released to surface 
waters. Therefore, EPA has not determined that the proposed processing 
or use of the substance may present an unreasonable risk. EPA has 
determined, however, that releases to surface waters may cause 
significant adverse environmental effects. Based on this information, 
the PMN substance meets the concern criteria at Sec.  
721.170(b)(4)(ii).
Recommended testing: EPA has determined that the results of the 
following testing would help characterize the PMN substance: An algal 
toxicity test (OPPTS 850.5400 test guideline (public draft)), a daphnid 
acute toxicity test (OPPTS 850.1010 test guideline (public draft)), and 
a fish acute toxicity test (OPPTS 850.1075 test guideline (public 
draft)).
CFR citation: 40 CFR 721.10014.
PMN Number P-01-110
Chemical name: Halogenated benzimidazole (generic).
CAS number: Not available.
Basis for action: The PMN states that the substance will be used as a 
dye intermediate. Based on Structure Activity Relationships (SAR) 
analysis, EPA expects toxicity to aquatic organisms to occur at 
concentrations as low as 1 ppb of the PMN substance in surface waters. 
In addition, EPA has identified environmental concerns because the PMN 
substance may be persistent, bioaccumulative, and toxic based on 
physical/chemical properties of the PMN substance, consistent with the 
New Chemical Program's PBT Category (64 FR 60194, November 4, 1999). As 
described in the PMN, the substance is not released to surface waters. 
Therefore, EPA has not determined that the proposed manufacturing, 
processing, or use of the substance may present an unreasonable risk. 
EPA has determined, however, that other uses of the substance resulting 
in release of the PMN substance to surface waters may cause significant 
adverse environmental effects, since the PMN substance has been 
characterized by EPA as a PBT. Based on this information, the PMN 
substance meets the concern criteria at Sec.  721.170(b)(4)(ii).
Recommended testing: EPA has determined that the results of the 
following tiered testing would help characterize the PMN substance: 
Tier 1 - Melting point/melting range test (OPPTS 830.7200 test 
guideline) and an octanol water partition coefficient/K<INF>ow</INF> 
test (OPPTS 830.7550 test guideline); Tier 2 - Activated sludge 
sorption isotherm (OPPTS 835.1110 test guideline) or modified 
coagulation-flocculation jar test of water (D2034-80); Tier 3 - An 
algal toxicity test (OPPTS 850.5400 test guideline (public draft)), a 
daphnid acute toxicity test (OPPTS 850.1010 test guideline (public 
draft)) and a fish acute toxicity test (OPPTS 850.1075 test guideline 
(public draft)); Tier 4 - tiered testing as described in the New 
Chemicals Program's PBT Category (excluding the octanol water partition 
coefficient/K<INF>ow</INF> test already recommended in Tier 1).
CFR citation: 40 CFR 721.10015.
PMN Number P-01-111
Chemical name: Dibenzimidazothianaphthalene (generic).
CAS number: Not available.
Basis for action: The PMN states that the substance will be used as a 
fluorescent dye. Based on toxicity data on structurally similar 
chemicals, EPA expects chronic toxicity to aquatic organisms to occur 
at concentrations as low as 1 ppb of the PMN substance in surface 
waters. As described in the PMN, the substance is not released to 
surface waters. Therefore, EPA has not determined that the proposed 
processing or use of the substance may present an unreasonable risk. 
EPA has determined, however, that releases to surface waters may cause 
significant adverse environmental effects. Based on this information, 
the PMN substance meets the concern criteria at Sec.  
721.170(b)(4)(ii).
Recommended testing: EPA has determined that the results of the 
following tiered testing would help characterize the PMN substance: 
Tier 1 - Activated sludge sorption isotherm test (OPPTS 835.1110 test 
guideline) or modified coagulation-flocculation jar test of water 
(D2034-80); Tier 2 - An algal toxicity test (OPPTS 850.5400 test 
guideline (public draft)), a daphnid acute toxicity test (OPPTS 
850.1010 test guideline (public draft)), and a fish acute toxicity test 
(OPPTS 850.1075 test guideline (public draft)); and Tier 3 - A daphnid 
chronic toxicity test (OPPTS 850.1300 test guideline (public draft)) 
and a fish early-life stage toxicity test (OPPTS 850.1400 test 
guideline (public draft)).
CFR citation: 40 CFR 721.10016.
PMN Numbers P-01-257/258/259 and P-01-261
Chemical name: Amine terminated bisphenol A diglycidyl ether polymer 
(generic).
CAS number: Not available.
Basis for action: The PMNs state that the substances will be used as 
epoxy resin curing agents. Based on analogy to structurally similar 
polycationic polymers, EPA is concerned that toxicity to aquatic 
organisms may occur at concentrations as low as 40 ppb in surface 
waters. As described in the PMNs, the substances are not released to 
surface waters. Therefore, EPA has not determined that the proposed 
manufacturing, processing, or use of the substances may present an 
unreasonable risk. EPA has determined, however, that other uses of the 
substances resulting in release to surface waters may cause significant 
adverse environmental effects. Based on this information, the PMN 
substances meet the concern criteria at Sec.  721.170(b)(4)(ii).
Recommended testing: EPA has determined that an algal toxicity test 
(OPPTS 850.5400 test guideline (public draft)), a daphnid acute 
toxicity test (OPPTS 850.1010 test guideline (public draft)), a fish 
acute toxicity test (OPPTS 850.1075 test guideline (public draft)), and 
a fish acute toxicity test mitigated by humic acid (OPPTS 850.1085 test 
guideline (public draft)) would help characterize the environmental 
effects of the PMN substances.
CFR citation: 40 CFR 721.10017.
PMN Number P-01-442
Chemical name: Calcium hydroxide oxide silicate 
(Ca<INF>6</INF>(OH)<INF>2</INF>O<INF>2</INF>(Si<INF>2</INF>O<INF>5</INF>
)<INF>3</INF>).
CAS number: 13169-90-9.
Basis for action: The PMN states that the substance will be used as a 
filler to reinforce resins, an additive for resins, and a filter 
medium. Based on test data on this chemical and structurally similar 
compounds, EPA has identified

[[Page 14687]]

human health concerns for cancer and toxicity to the respiratory tract, 
lungs, respiratory system, and liver to workers exposed via inhalation. 
As described in the PMN, significant worker exposure is unlikely. 
Therefore, EPA has not determined that the proposed import, processing, 
or use of the substance may present an unreasonable risk. EPA has 
determined, however, that domestic manufacture, uses other than as 
described in the PMN, or processing or use as a powder resulting in 
significant worker inhalation exposure may cause significant adverse 
human health effects. Based on this information, the PMN substance 
meets the concern criteria at Sec.  721.170 (b)(1)(i)(C), (b)(3)(i), 
and (b)(3)(ii).
Recommended testing: EPA has determined that a 90-day inhalation 
toxicity study (OPPTS 870.3465 test guideline) would help characterize 
the human health effects of the PMN substance.
CFR citation: 40 CFR 721.10018.
PMN Number P-01-563
Chemical name: Benzoic acid, 2-chloro-5-nitro-, 1,1-dimethyl-2-oxo-2-
(2-propenyloxy) ethyl ester.
CAS number: 174489-76-0.
Basis for action: The PMN states that the substance will be used as a 
chemical intermediate. Based on submitted test data and on structural 
analogy to esters, EPA is concerned that toxicity to aquatic organisms 
may occur at concentrations as low as 3 ppb of the PMN substance in 
surface waters. As described in the PMN, the substance is not released 
to surface waters. Therefore, EPA has not determined that the proposed 
manufacturing, processing, or use of the substance may present an 
unreasonable risk. EPA has determined, however, that other uses of the 
substance resulting in release to surface waters may cause significant 
adverse environmental effects. Based on this information, the PMN 
substance meets the concern criteria at Sec.  721.170 (b)(4)(i) and 
(b)(4)(ii).
Recommended testing: EPA has determined that a fish acute toxicity test 
(OPPTS 850.1075 test guideline (public draft)), a daphnid acute 
toxicity test (OPPTS 850.1010 test guideline (public draft)), an algal 
toxicity test (OPPTS 850.5400 test guideline (public draft)), and an 
aerobic aquatic biodegradation test with an analytical methodology to 
identify the isononyl phenol degradation product (OPPTS 835.3100 test 
guideline) would help characterize the environmental effects of the PMN 
substance.
CFR citation: 40 CFR 721.10019.
PMN Number P-01-564
Chemical name: Benzoic acid, 5-amino-2-chloro-, 1,1-dimethyl-2-oxo-2-
(2-propenyloxy) ethyl ester.
CAS number: 174489-43-1.
Basis for action: The PMN states that the substance will be used as a 
chemical intermediate. Based on structural analogy to anilines, EPA is 
concerned that toxicity to aquatic organisms may occur at 
concentrations as low as 1 ppb of the PMN substance in surface waters. 
As described in the PMN, the substance is not released to surface 
waters. Therefore, EPA has not determined that the proposed 
manufacturing, processing, or use of the substance may present an 
unreasonable risk. EPA has determined, however, that other uses of the 
substance resulting in release to surface waters may cause significant 
adverse environmental effects. Based on this information, the PMN 
substance meets the concern criteria at Sec.  721.170(b)(4)(ii).
Recommended testing: EPA has determined that a fish acute toxicity test 
(OPPTS 850.1075 test guideline (public draft)), a daphnid acute 
toxicity test (OPPTS 850.1010 test guideline (public draft)), an algal 
toxicity test (OPPTS 850.5400 test guideline (public draft)), and an 
aerobic aquatic biodegradation test with an analytical methodology to 
identify the isononyl phenol degradation product (OPPTS 835.3100 test 
guideline) would help characterize the environmental effects of the PMN 
substance.
CFR citation: 40 CFR 721.10020.
PMN Number P-01-764
Chemical name: Magnesium potassium titanium oxide.
CAS number:39290-90-9.
Effective date of section 5(e) consent order: July 29, 2002.
Basis for section 5(e) consent order: The PMN states that the generic 
(non-confidential) use of the substance will be as a physical 
characteristics modifier for industrial use in certain solid composite 
articles. The order was issued under section 5(e)(1)(A)(i) and 
(e)(1)(A)(ii)(I) of TSCA based on a finding that this substance may 
present an unreasonable risk of injury to human health. To protect 
against this risk, the consent order requires worker protection and 
hazard communication and restricts the aggregate manufacture/
importation volume of the PMN substance. The SNUR designates as a 
`significant new use' the absence of these protective measures.
Toxicity concern: Based on test data on titanium dioxide, EPA has 
health concerns for lung toxicity, including lung overload and 
oncogenicity, with inhalation exposure. The NCEL is 5 mg/m\3\ as an 8-
hour time-weighted average.
Recommended testing: EPA has determined that the results of a 90-day 
inhalation toxicity study with a 60-day holding period (OPPTS 870.3465 
test guideline) and possibly a 2-year carcinogenicity study (OPPTS 
870.4200 test guideline) would help characterize the human health 
effects of the PMN substance. The consent order contains two production 
volume limits. The PMN submitter agreed not to exceed the first 
production volume limit without performing the 90-day inhalation 
toxicity study and not to exceed the second production volume limit 
without performing the 2-year carcinogenicity study if warranted based 
on the results of the first study.
CFR citation: 40 CFR 721.10021.
PMN Numbers P-01-769/770/771/772
Chemical names: (P-01-769) Benzenamine, N-phenyl-, ar-(C<INF>9</INF>-
rich C<INF>8-10</INF>-branched alkyl) derivs; (P-01-770) Benzenamine, 
N-phenyl-, ar, ar'-(C<INF>9</INF>-rich C<INF>8-10</INF>-branched alkyl) 
derivs; (P-01-771) 10H-Phenothiazine, ar-(C<INF>9</INF>-rich 
C<INF>8-10</INF>-branched alkyl) derivs; and (P-01-772) 10H-
Phenothiazine, ar, ar'-(C<INF>9</INF>-rich C<INF>8-10</INF>-branched 
alkyl) derivs.
CAS numbers: (P-01-769) 333955-69-4, (P-01-770) 333955-70-7, (P-01-771) 
333955-79-6, and (P-01-772) 333955-80-9.
Basis for action: The PMNs state that the substances will be used as 
antioxidants for lubricating oils. EPA has identified human health and 
environmental concerns because the PMN substances may be persistent, 
bioaccumulative, and toxic, based on submitted test data and physical/
chemical properties of the PMN substances, consistent with the New 
Chemical Program's PBT Category (64 FR 60194, November 4, 1999). As 
described in the PMNs, significant worker exposure is unlikely and the 
substances are not released to surface waters. Therefore, EPA has not 
determined that the proposed manufacturing, processing, or use of the 
PMN substances may present an unreasonable risk. EPA has determined, 
however, that use of the PMN substances other than as described in the 
PMNs resulting in release to water may cause serious chronic human 
health effects and significant environmental effects, since the PMN 
substances have been characterized by EPA as a PBT. Based on this 
information, the PMN substances meet the concern criteria at Sec.  
721.170 (b)(3)(i), (b)(4)(ii), and (b)(4)(iii).
Recommended testing: EPA has determined that the results of testing 
Tiers 2 and 3 as described in the New

[[Page 14688]]

Chemicals Program's PBT Category would help characterize the PBT 
attributes of the PMN substances.
CFR citations: 40 CFR 721.10022 (P-01-769); 40 CFR 721.10023 (P-01-
770); 40 CFR 721.10024 (P-01-771); and 40 CFR 721.10025 (P-01-772).
PMN Number P-01-856
Chemical name: Cashew, nutshell liq., ethoxylated.
CAS number: 350820-95-0.
Effective date of section 5(e) consent order: July 5, 2002.
Basis for section 5(e) consent order: The PMN states that the substance 
will be used as a pigment dispersant. The order was issued under 
section 5(e)(1)(A)(i) and (e)(1)(A)(ii)(I) of TSCA based on a finding 
that this substance may present an unreasonable risk of injury to the 
environment. To protect against this risk, the consent order restricts 
molecular weight and composition of the PMN substance. The SNUR 
designates as a `significant new use' the absence of these protective 
measures.
Toxicity concern: Based on test data on structurally similar nonionic 
surfactants, particularly alkyl ethoxylate, EPA has concerns that the 
environmental toxicity of the PMN substance varies depending on the 
average number of moles of the ethoxy. As the number of moles of ethoxy 
decreases, the aquatic toxicity of the substance increases. For this 
PMN substance, the average number of moles may vary. When the average 
number of moles of the ethoxy group is 80, EPA expects toxicity to 
aquatic organisms to occur at concentrations as low as 1,000 ppb.
Recommended testing: The Agency has determined that the results of a 
fish acute toxicity test (OPPTS 850.1075 test guideline (public 
draft)), a daphnid acute toxicity test (OPPTS 850.1010 test guideline 
(public draft)), and an algal toxicity test (OPPTS 850.5400 test 
guideline (public draft)) would help characterize possible 
environmental effects of the substance. The tests should be conducted 
on the PMN substance with less than 55 moles of the ethoxy group or 
with an average molecular weight less than 2,700 daltons.
CFR citation: 40 CFR 721.10026.
PMN Number P-01-862
Chemical name: Ethoxylated alkylsulfate, substituted alkylamine salt 
(generic).
CAS number: Not available.
Basis for action: The PMN states that the generic (non-confidential) 
use of the substance will be as a processing aid. Based on analogy to 
cationic surfactants and similar substances, EPA is concerned that 
chronic toxicity to aquatic organisms may occur at concentrations as 
low as 4 ppb of the PMN substance in surface waters. As described in 
the PMN, the substance is not released to surface waters in significant 
quantities. Therefore, EPA has not determined that the proposed 
manufacturing, processing, or use of the substance may present an 
unreasonable risk. EPA has determined, however, that other uses of the 
substance resulting in significant release to surface waters may cause 
significant adverse environmental effects. Based on this information, 
the PMN substance meets the concern criteria at Sec.  
721.170(b)(4)(ii).
Recommended testing: EPA has determined that a fish early-life stage 
toxicity test (OPPTS 850.1400 test guideline (public draft)), a daphnid 
chronic toxicity test (OPPTS 850.1300 test guideline (public draft)), 
and a ready biodegradability test (OPPTS 835.3110 test guideline) would 
help characterize the chronic environmental effects and the fate in the 
environment of the PMN substance. After this testing is completed, if 
the results of the testing and projected environmental risk warrant it, 
a porous pot test (OPPTS 835.3220 test guideline) or modified semi-
continuous activated sludge (SCAS) test (OPPTS 835.3210 test guideline) 
would further characterize the environmental fate of this substance.
CFR citation: 40 CFR 721.10027.
PMN Numbers P-01-901 and P-01-902
Chemical name: Disubstituted benzene metal salt (generic).
CAS number: Not available.
Basis for action: The PMNs state that the generic (non-confidential) 
use of the substances will be as a polymer additive. Based on test data 
and analogy to phenols and hydroquinones/quinones, EPA has concerns for 
dermal corrosivity, acute toxicity, kidney and liver effects, 
mutagenicity, carcinogenicity, neurotoxicity, developmental toxicity, 
depigmentation of skin, thyroid effects, and sensitization. Also, based 
on analogy to phenols and hydroquinones/quinones, EPA is concerned that 
toxicity to aquatic organisms may occur at concentrations as low as 1 
ppb in surface waters. As described in the PMNs, significant worker 
exposure is not expected as workers wear impervious personal protective 
equipment and significant environmental exposure is not expected as the 
substances are not released to surface waters in significant 
quantities. Therefore, EPA has not determined that the proposed 
manufacturing, processing, or use of the substances may present an 
unreasonable risk. EPA has determined, however, that use of the 
substances without workers wearing impervious gloves or uses other than 
as described in the PMNs could result in serious health effects or 
significant adverse environmental effects. Based on this information, 
the PMN substances meet the concern criteria at Sec.  721.170 
(b)(1)(i)(C), (b)(3)(i), (b)(3)(ii), and (b)(4)(ii).
Recommended testing: EPA has determined that an algal toxicity test 
(OPPTS 850.5400 test guideline (public draft)), a daphnid acute 
toxicity test (OPPTS 850.1010 test guideline (public draft)), and a 
fish acute toxicity test (OPPTS 850.1075 test guideline (public draft)) 
would help characterize the environmental effects of the PMN 
substances. EPA has also determined that a 90-day inhalation toxicity 
study with a 60-day holding period (OPPTS 870.3465 test guideline) 
would help characterize the human health effects.
CFR citation: 40 CFR 721.10028.
PMN Number P-01-918
Chemical name: Isocyanate compound, modified with methoxysilane 
(generic).
CAS number: Not available.
Effective date of section 5(e) consent order: May 30, 2002.
Basis for section 5(e) consent order: The PMN states that the generic 
(non-confidential) use of the substance will be as a sealant. The order 
was issued under section 5(e)(1)(A)(i) and (e)(1)(A)(ii)(I) of TSCA 
based on a finding that this substance may present an unreasonable risk 
of injury to human health. To protect against this risk, the consent 
order requires worker protection and hazard communication and restricts 
the aggregate manufacture/importation volume of the PMN substance. The 
SNUR designates as a `significant new use' the absence of these 
protective measures.
Toxicity concern: Based on test data on diisocyanates, the Agency has 
concern for dermal and respiratory sensitization and pulmonary 
toxicity. The NCEL is 0.05 mg/m\3\ or 0.005 ppm as an 8-hour time-
weighted average.
Recommended testing: EPA has determined that the results of a skin 
sensitization study (OPPTS 870.2600 test guideline) and a 90-day 
inhalation toxicity study (OPPTS 870.3465 test guideline) would help 
characterize the human health effects of the substance.
CFR citation: 40 CFR 721.10029.
PMN Number P-01-919
Chemical name: Pyrimido[5,4-g]pteridine-2,4,6,8-tetramine, 4-
methylbenzenesulfonate, base-hydrolyzed.

[[Page 14689]]

CAS number: 346709-25-9.
Basis for action: The PMN states that the substance will be used as a 
pigment for thermoplastic polymers. Based on analogy to structurally 
similar N-heterocyclic chemicals, EPA has concerns for potential 
developmental toxicity from exposure to the PMN material. Significant 
worker exposure is unlikely when the substance is used as described in 
the PMN. In addition, based on test data on the PMN substance, EPA is 
concerned that chronic toxicity to aquatic organisms may occur at 
concentrations as low as 10 ppb in surface waters. As described in the 
PMN, the substance is not released to surface waters in significant 
quantities. Therefore, EPA has not determined that the proposed 
manufacturing, processing, or use of the substance may present an 
unreasonable risk. EPA has determined, however, that domestic 
manufacture of the substance may cause serious health effects and 
significant environmental effects. Based on this information, the PMN 
substance meets the concern criteria at Sec.  721.170 (b)(3)(ii) and 
(b)(4)(i).
Recommended testing: EPA has determined that a combined repeated dose 
toxicity study with the reproduction/developmental toxicity screening 
test (OPPTS 870.3650 test guideline), a daphnid chronic toxicity test 
(OPPTS 850.1300 test guideline (public draft)), and a fish early-life 
stage toxicity test (OPPTS 850.1400 test guideline (public draft)) 
would help characterize the human health and environmental effects of 
the substance.
CFR citation: 40 CFR 721.10030.
PMN Number P-02-214
Chemical name: Lithium potassium titanium oxide.
CAS number: 39318-30-4.
Effective date of section 5(e) consent order: June 17, 2002.
Basis for section 5(e) consent order: The PMN states that the generic 
(non-confidential) use of the substance will be as a physical 
characteristics modifier for industrial use in certain solid composite 
articles. The order was issued under section 5(e)(1)(A)(i) and 
(e)(1)(A)(ii)(I) of TSCA based on a finding that this substance may 
present an unreasonable risk of injury to human health. To protect 
against this risk, the consent order requires worker protection and 
hazard communication and restricts the aggregate manufacture/
importation volume of the PMN substance. The SNUR designates as a 
`significant new use' the absence of these protective measures.
Toxicity concern: Based on test data on titanium dioxide, the Agency 
has concerns for lung toxicity (including oncogenicity) if the PMN 
substance is inhaled. The NCEL is 5 mg/m\3\ as an 8-hour time-weighted 
average.
Recommended testing: EPA has determined that the results of a 90-day 
inhalation toxicity study with a 60-day holding period (OPPTS 870.3465 
test guideline) and possibly a 2-year carcinogenicity study (OPPTS 
870.4200 test guideline) would help characterize the human health 
effects of the PMN substance. The consent order contains two production 
volume limits. The PMN submitter agreed not to exceed the first 
production volume limit without performing the 90-day inhalation 
toxicity study and not to exceed the second production volume limit 
without performing the 2-year carcinogenicity study if warranted based 
on the results of the first study.
CFR citation: 40 CFR 721.10031.
PMN Number P-02-269
Chemical name: Acrylic acid, polymer with substituted acrylamides 
(generic).
CAS number: Not available.
Effective date of section 5(e) consent order: October 22, 2002.
Basis for section 5(e) consent order: The PMN states that the generic 
(non-confidential) use of the substance will be as a thermo-sensitive 
water absorbing/desorbing polymer to soil. The order was issued under 
section 5(e)(1)(A)(i) and (e)(1)(A)(ii)(I) of TSCA based on a finding 
that this substance may present an unreasonable risk of injury to human 
health. To protect against this risk, the consent order restricts the 
particle size of the PMN substance. The SNUR designates as a 
`significant new use' the absence of this protective measure.
Toxicity concern: Based on test data on swellable high molecular weight 
polymers (see 60 FR 16319-16320, March 29, 1995) (FRl-4921-9), the 
Agency has concerns for lung toxicity and oncogenicity if the PMN 
substance is inhaled.
Recommended testing: The Agency has determined that a 90-day inhalation 
toxicity study (OPPTS 870.3465 test guideline) and a carcinogenicity 
study (OPPTS 870.4200 test guideline) would help characterize possible 
human health effects of the substance.
CFR citation: 40 CFR 721.10032.
PMN Number P-02-322
Chemical name: Zinc, [ethanedioato(2-)-. kappa. O\1\, . kappa. O\2\]-.
CAS number: 547-68-2.
Basis for action: The PMN states that the generic (non-confidential) 
use of the substance will be as an intermediate. Based on analogy to 
similar zinc compounds, EPA is concerned that toxicity to aquatic 
organisms may occur at concentrations above 1 ppb in surface waters. As 
described in the PMN, releases of the substance are not expected to 
result in surface water concentrations above 1 ppb. Therefore, EPA has 
not determined that the proposed manufacturing, processing, or use of 
the PMN substance may cause significant adverse effects. EPA has 
determined, however, that other uses of the PMN substance resulting in 
surface water concentrations above 1 ppb may cause significant adverse 
environmental effects. Based on this information, the PMN substance 
meets the concern criteria at Sec.  721.170(b)(4)(ii).
Recommended testing: EPA has determined that the results of an algal 
toxicity test (OPPTS 850.5400 test guideline (public draft)), a fish 
early-life stage toxicity test (OPPTS 850.1400 test guideline (public 
draft)), and a daphnid chronic toxicity test (OPPTS 850.1300 test 
guideline (public draft)) would help characterize the environmental 
effects of the PMN substance.
CFR citation: 40 CFR 721.10033.
PMN Number P-02-359
Chemical name: Substituted pyridine coupled with diazotized substituted 
nitrobenzonitrile, diazotized substituted benzenamine and substituted 
pyridinecarbonitrile (generic).
CAS number: Not available.
Basis for action: The PMN states that the generic (non-confidential) 
use of the substance will be as a textile dye. Based on structural 
analogy to neutral organics, EPA is concerned that chronic toxicity to 
aquatic organisms may occur at concentrations above 1 ppb of the PMN 
substance in surface waters. As described in the PMN, the substance is 
not released to surface waters in significant quantities. Therefore, 
EPA has not determined that the proposed manufacturing, processing, or 
use of the substance may present an unreasonable risk. EPA has 
determined, however, that other uses of the substance resulting in 
release to surface waters in concentrations above 1 ppb may cause 
significant adverse environmental effects. Based on this information, 
the PMN substance meets the concern criteria at Sec.  
721.170(b)(4)(ii).
Recommended testing: EPA has determined that a fish early-life toxicity 
test (OPPTS 850.1400 test guideline (public draft)), a daphnid chronic 
toxicity test (OPPTS 850.1300 test guideline (public draft)), and an 
algal toxicity test (OPPTS 850.5400 test guideline (public draft)) 
would help characterize the environmental effects of the PMN substance.
CFR citation: 40 CFR 721.10034.
PMN Number P-02-382
Chemical name: Alkylbenzene sulfonate (generic).

[[Page 14690]]

CAS number: Not available.
Effective date of section 5(e) consent order: December 17, 2002.
Basis for section 5(e) consent order: The PMN states that the generic 
(non-confidential) use of the substance will be as a petroleum 
lubricant additive. The order was issued under section 5(e)(1)(A)(i) 
and (e)(1)(A)(ii)(I) of TSCA based on a finding that this substance may 
present an unreasonable risk of injury to the environment. To protect 
against this risk, the consent order restricts the formulation of the 
PMN substance. The SNUR designates as a `significant new use' the 
absence of this protective measure. In addition, the order was issued 
under section 5(e)(1)(A)(ii)(II) of TSCA based on a finding that this 
substance will be produced in substantial quantities and may reasonably 
be anticipated to enter the environment in substantial quantities.
Toxicity concern: Based on analogy to structurally similar anionic 
surfactants, EPA expects toxicity to aquatic organisms to occur at 
concentrations as low as 500 ppb in surface waters. However, when the 
PMN substance is manufactured, processed, and used in mineral oil as 
described in the PMN, EPA does not expect releases of this PMN 
substance to pose a risk to the environment. The oil diluent serves to 
minimize dispersion and bioavailability of the PMN substance in surface 
waters. EPA has determined that other uses of the substance when not 
diluted in mineral oil may result in significant release to surface 
waters and may cause significant adverse environmental effects.
Recommended testing: EPA has determined that an algal toxicity test 
(OPPTS 850.5400 test guideline (public draft)), a daphnid acute 
toxicity test (OPPTS 850.1010 test guideline (public draft)), and a 
fish acute toxicity test (OPPTS 850.1075 test guideline (public draft)) 
would help characterize the environmental effects of the PMN substance 
when not used in mineral oil.
CFR citation: 40 CFR 721.10035.
PMN Number P-02-406
Chemical name: Acetaldehyde based polymer (generic).
CAS number: Not available.
Basis for action: The PMN states that the generic (non-confidential) 
use of the substance will be as a corrosion inhibitor. EPA has 
identified health and environmental concerns for this substance. EPA 
has identified health concerns for carcinogenicity and dermal 
sensitization based on analogy to structurally similar chemicals. Based 
on structural analogy to aldehydes, EPA is concerned that toxicity to 
aquatic organisms may occur at concentrations as low as 1 ppb of the 
PMN substance in surface waters. In addition, the PMN substance may be 
persistent, bioaccumulative, and potentially toxic based on physical/
chemical properties of the PMN substance as described in the New 
Chemical Program's PBT Category (64 FR 60194, November 4, 1999). As 
described in the PMN, significant worker exposure is unlikely and the 
substance is not released to surface waters. Therefore, EPA has not 
determined that the proposed manufacturing, processing, or use of the 
PMN substance may present an unreasonable risk. EPA has determined, 
however, that other domestic manufacturing or other uses that result in 
predictable or purposeful releases to surface water could result in 
exposures which may cause serious chronic human health effects and 
significant environmental effects since the substance has been 
characterized by EPA as a PBT. Based on this information, the PMN 
substance meets the concern criteria at Sec.  721.170 (b)(1)(i)(C), 
(b)(3)(ii), and (b)(4)(ii).
Recommended testing: EPA has determined that the results of the tiered 
testing as described in the New Chemicals Program's PBT Category would 
help characterize the PBT attributes of the PMN substance.
CFR citation: 40 CFR 721.10036.
PMN Number P-02-423
Chemical name: Complex halogenated salt of tris(ethylated 
aminocarbocyclic)methane (generic).
CAS number: Not available.
Basis for action: The PMN states that the substance will be used as a 
colorant for inks. Based on structurally similar compounds, EPA has 
identified human health concerns for carcinogenicity, mutagenicity, 
reproductive effects, and developmental effects from inhalation 
exposure to the PMN substance. In addition, based on structurally 
similar compounds, EPA expects toxicity to aquatic organisms at surface 
water concentrations above 1 ppb. As described in the PMN, significant 
worker and environmental exposure are unlikely. Therefore, EPA has not 
determined that the proposed manufacturing, processing, or use of the 
substance may present an unreasonable risk. EPA has determined, 
however, that other uses of the substance resulting in surface water 
concentrations above 1 ppb or any processing or use beyond the site of 
manufacture or import could result in worker and environmental 
exposures which may cause carcinogenic and serious chronic effects in 
humans and significant environmental effects. Based on this 
information, the PMN substance meets the concern criteria at Sec.  
721.170 (b)(1)(i)(C), (b)(3)(ii), and (b)(4)(ii).
Recommended testing: EPA has determined that a prenatal developmental 
toxicity study by the oral route (OPPTS 870.3700 test guideline), a 
reproductive and fertility effects study (OPPTS 870.3800 test 
guideline), a Salmonella typhimurium reverse mutation assay (40 CFR 
798.5265), and a mammalian erythrocyte micronucleus study by the 
intraperitoneal route (OPPTS 870.5395 test guideline) would help 
characterize the human health effects of the PMN substance. Positive 
results in the mutagencity studies would trigger a carcinogenicity 
study (OPPTS 870.4200 test guideline). In addition, EPA has determined 
that a fish acute toxicity test (OPPTS 850.1075 test guideline (public 
draft)), a daphnid acute toxicity test (OPPTS 850.1010 test guideline 
(public draft)), and an algal toxicity test (OPPTS 850.5400 test 
guideline (public draft)) would help characterize the environmental 
effects of the PMN substance.
CFR citation: 40 CFR 721.10037.
PMN Number P-02-434
Chemical name: Trimellitic anhydride, polymer with substituted glycol, 
alkyl phenols and ethoxylated nonylphenol (generic).
CAS number: Not available.
Basis for action: The PMN states that the substance will be used as 
curing resin for industrial can coatings. Based on structural analogy 
to esters, EPA is concerned that toxicity to aquatic organisms may 
occur at concentrations as low as 1 ppb of the PMN substance in surface 
waters. As described in the PMN, the substance is not released to 
surface waters. Therefore, EPA has not determined that the proposed 
manufacturing, processing, or use of the substance may present an 
unreasonable risk. EPA has determined, however, that other uses of the 
substance resulting in release to surface waters may cause significant 
adverse environmental effects. Based on this information, the PMN 
substance meets the concern criteria at Sec.  721.170(b)(4)(ii).
Recommended testing: EPA has determined that an aerobic biodegradation 
test with an analytical methodology to identify the branched-nonyl 
phenol degradation product (OPPTS 835.3100 test guideline) would help 
characterize the environmental effects of the PMN substance.
CFR citation: 40 CFR 721.10038.
PMN Number P-02-514

[[Page 14691]]

Chemical name: Diethoxybenzenamine derivative, diazotized, coupled with 
aminonaphthalenesulfonic acid derivative, ammonium salt (generic).
CAS number: Not available.
Basis for action: The PMN states that the generic (non-confidential) 
use of the substance will be as a dyestuff in printing ink. Based on 
structural analogy, EPA has identified concerns for carcinogenicity, 
mutagenicity, and developmental toxicity for the substituted beta-
naphthylamine azo reduction product, blood and developmental toxicity 
for the aniline-acid-based azo reduction product, and carcinogenicity, 
developmental, liver toxicity and sensitization for the para-
phenylenediamine-based azo reduction product. There is concern for 
chronic effects based on the submitted 28-day subchronic study with a 
No Observed Adverse Effect Level (NOAEL) of 15 mg/kg. As described in 
the PMN, worker inhalation exposures are not expected. Therefore, EPA 
has not determined that the proposed manufacturing, processing, or use 
of the substance may present an unreasonable risk. EPA has determined, 
however, that domestic manufacture or processing or use of the 
substance as a solid may cause serious health effects. Based on this 
information, the PMN substance meets the concern criteria at Sec.  
721.170 (b)(1)(i)(C), (b)(3)(i), (b)(3)(ii), and (b)(3)(iii).
Recommended testing: EPA has determined that a prenatal developmental 
toxicity study by the oral route in two species (40 CFR 799.9370), an 
Ames assay with the Prival modification with a concurrent positive 
control (OPPTS 870.5100 test guideline), and a 90-day inhalation 
toxicity study in rats (OPPTS 870.3465 test guideline) would help 
characterize the human health effects of the PMN substance.
CFR citation: 40 CFR 721.10039.
PMN Number P-02-522
Chemical name: Substituted acridine naphtha substituted benzamide 
(generic).
CAS number: Not available.
Basis for action: The PMN states that the generic (non-confidential) 
use of the substance will be in exhaust dyeing of polyester fibers. 
Based on analogy to neutral organics, EPA is concerned that toxicity to 
aquatic organisms may occur at concentrations above 2 ppb of the PMN 
substance in surface waters. As described in the PMN, releases of the 
substance are not expected to result in surface water concentrations 
above 2 ppb. Therefore, EPA has not determined that the proposed 
manufacturing, processing, or use of the substance may present an 
unreasonable risk. EPA has determined, however, that other uses of the 
substance resulting in release to surface waters in concentrations 
above 2 ppb may cause significant adverse environmental effects. Based 
on this information, the PMN substance meets the concern criteria at 
Sec.  721.170(b)(4)(ii).
Recommended testing: EPA has determined that the results of an algal 
toxicity test (OPPTS 850.5400 test guideline (public draft)), a fish 
chronic toxicity test (OPPTS 850.1400 test guideline (public draft)), 
and a daphnid chronic toxicity test (OPPTS 850.1300 test guideline 
(public draft)) would help characterize the environmental effects of 
the PMN substance.
CFR citation: 40 CFR 721.10040.
PMN Number P-02-530
Chemical name: 1-Butanone, 2-(dimethylamino)-2-[(4-
methylphenyl)methyl]-1-[4-(4-morpholinyl)phenyl]-.
CAS number: 119344-86-4.
Basis for action: The PMN states that the substance will be used as a 
photo initiator for coatings and inks. Based on structural analogy to 
aliphatic amines, EPA is concerned that toxicity to aquatic organisms 
may occur at concentrations as low as 2 ppb of the PMN substance in 
surface waters. As described in the PMN, the substance is not released 
to surface waters in significant quantities. Therefore, EPA has not 
determined that the proposed manufacturing, processing, or use of the 
substance may present an unreasonable risk. EPA has determined, 
however, that domestic manufacture of the PMN substance may result in 
significant adverse environmental effects. Based on this information, 
the PMN substance meets the concern criteria at Sec.  
721.170(b)(4)(ii).
Recommended testing: EPA has determined that a fish acute toxicity test 
(OPPTS 850.1075 test guideline (public draft)), a daphnid acute 
toxicity test (OPPTS 850.1010 test guideline (public draft)), and an 
algal toxicity test (OPPTS 850.5400 test guideline (public draft)) 
would help characterize the environmental effects of the PMN substance.
CFR citation: 40 CFR 721.10041.
PMN Number P-02-585
Chemical name: 2-Propanol, 1-[bis(2-hydroxyethyl)amino]-.
CAS number: 6712-98-7.
Basis for action: The PMN states that the generic (non-confidential) 
use of the substance will be as a grinding aid and intermediate. EPA 
has identified health concerns for lung sensitization and 
carcinogenicity based on analogy to triethanolamine. There is concern 
for developmental toxicity, eye irritation, liver toxicity, kidney 
toxicity, and blood toxicity based on submitted test data. As described 
in the PMN, significant inhalation exposure is unlikely. Therefore, EPA 
has not determined that the proposed manufacturing, processing, or use 
of the substance may present an unreasonable risk. EPA has determined, 
however, that other uses of the substance other than as described in 
the PMN may result in significant human exposure. Based on this 
information, the PMN substance meets the concern criteria at Sec.  
721.170 (b)(1)(i)(C), (b)(3)(i), and (b)(3)(ii).
Recommended testing: EPA has determined that a prenatal developmental 
toxicity study by the oral route in rats (OPPTS 870.3700 test 
guideline) would help characterize the human health effects of the PMN 
substance.
CFR citation: 40 CFR 721.10042.
PMN Number P-02-697
Chemical name: Dineopentyl-4-substituted phthalate (generic).
CAS number: Not available.
Basis for action: The PMN states that the generic (non-confidential) 
use of the substance will be as a catalyst component. EPA has 
identified health and environmental concerns because the PMN substance 
may be persistent, bioaccumulative, and toxic based on physical/
chemical properties of the PMN substance as described in the New 
Chemical Program's PBT Category (64 FR 60194, November 4, 1999). EPA 
has identified health concerns for developmental toxicity based on 
analogy to other phthalates and concerns for liver, kidney, and 
neurotoxicity based on analogy to haloaromatic compounds. As described 
in the PMN, significant worker exposure is unlikely and the substance 
is not released to surface waters. Therefore, EPA has not determined 
that the proposed manufacturing, processing, or use of the PMN 
substance may present an unreasonable risk. EPA has determined, 
however, that other uses of the PMN substance which may result in 
predictable or purposeful release of the PMN substance into waters of 
the United States or any use of the PMN substance other than as 
described in the PMN could result in exposures which may cause serious 
chronic human health effects and significant

[[Page 14692]]

environmental effects since the PMN substance has been characterized by 
EPA as a PBT. Based on this information, the PMN substance meets the 
concern criteria at Sec.  721.170 (b)(3)(ii) and (b)(4)(ii).
Recommended testing: EPA has determined that the results of the tiered 
testing as described in the New Chemicals Program's PBT Category would 
help characterize the PBT attributes of the PMN substance.
CFR citation: 40 CFR 721.10043.
PMN Number P-02-698
Chemical name: Metal oxide, modified with alkyl and vinyl terminated 
polysiloxanes (generic).
CAS number: Not available.
Basis for action: The PMN states that the substance will be used as an 
adhesive. EPA has identified health concerns for lung toxicity based on 
analogy to poorly soluble respirable particulates. As described in the 
PMN, significant worker exposure is unlikely. Therefore, EPA has not 
determined that the proposed manufacturing, processing, or use of the 
substance may present an unreasonable risk. EPA has determined, 
however, that manufacturing, processing, or use of the substance as a 
powder could result in exposures which may cause serious health 
effects. Based on this information, the PMN substance meets the concern 
criteria at Sec.  721.170(b)(3)(ii).
Recommended testing: EPA has determined that a 90-day inhalation 
toxicity study in rodents with a 60-day holding period (OPPTS 870.3465 
test guideline) would help characterize the human health effects of the 
PMN substance.
CFR citation: 40 CFR 721.10044.
PMN Number P-02-737
Chemical name: Diazotized substituted heteromonocycle coupled with 
naphthalene sulfonic acid derivative, nickel complex, alkaline salt 
(generic).
CAS number: Not available.
Basis for action: The PMN states that the generic (non-confidential) 
use of the substance will be as a colorant for coating compositions. 
EPA has identified concerns for carcinogenicity, pulmonary 
sensitization, immunotoxicity, developmental toxicity, and 
neurotoxicity from analogous compounds, and carcinogenicity, 
mutagenicity, and developmental toxicity for the azo reduction 
products. As described in the PMN, worker inhalation exposure is not 
expected. Therefore, EPA has not determined that the proposed 
manufacturing, processing, or use of the substance may present an 
unreasonable risk. EPA has determined, however, that domestic 
manufacture or processing or use of the substance as a solid may cause 
serious health effects. Based on this information, the PMN substance 
meets the concern criteria at Sec.  721.170 (b)(1)(i)(C), (b)(1)(i)(D), 
(b)(3)(ii), and (b)(3)(iii).
Recommended testing: EPA has determined that a 90-day oral toxicity 
test in rodents (OPPTS 870.3100 test guideline), a bacterial reverse 
mutation test with Prival modification (OPPTS 870.5100 test guideline), 
and an unscheduled DNA synthesis test in rat hepatocytes (OPPTS 
870.5550 test guideline) would help characterize the human health 
effects of the PMN substance. If warranted by the results of any of the 
three above studies, a carcinogenicity test (OPPTS 870.4200 test 
guideline) is recommended.
CFR citation: 40 CFR 721.10045.
PMN Number P-02-747
Chemical name: Polyaromatic amine phosphate (generic).
CAS number: Not available.
Basis for action: The PMN states that the substance will be used as a 
film additive. Based on structural analogy to soluble nonionic dyes and 
inorganic phosphates, EPA is concerned that toxicity to aquatic 
organisms may occur at concentrations as low as 10 ppb of the PMN 
substance in surface waters. As described in the PMN, the substance is 
not released to surface waters. Therefore, EPA has not determined that 
the proposed manufacturing, processing, or use of the substance may 
present an unreasonable risk. EPA has determined, however, that other 
uses of the substance resulting in release to surface waters may cause 
significant adverse environmental effects. Based on this information, 
the PMN substance meets the concern criteria at Sec.  
721.170(b)(4)(ii).
Recommended testing: EPA has determined that a fish acute toxicity test 
(OPPTS 850.1075 test guideline (public draft)), a daphnid acute 
toxicity test (OPPTS 850.1010 test guideline (public draft)), and an 
algal toxicity test (OPPTS 850.5400 test guideline (public draft)) 
would help characterize the environmental effects of the PMN substance.
CFR citation: 40 CFR 721.10046.
PMN Number P-02-766
Chemical name: Polyphosphoric acids, compds. with piperazine.
CAS number: 383905-85-9.
Basis for action: The PMN states that the generic (non-confidential) 
use of the substance will be as a flame retardant. Based on analogy to 
aliphatic amines and inorganic phosphates, EPA is concerned that 
toxicity to aquatic organisms may occur at concentrations as low as 10 
ppb of the PMN substance in surface waters. As described in the PMN, 
the substance is not released to surface waters in significant 
quantities. Therefore, EPA has not determined that the proposed 
manufacturing or use of the substance may present an unreasonable risk. 
EPA has determined, however, that use of the substance other than as 
described in the PMN could result in exposures which may cause 
significant adverse environmental effects. Based on this information, 
the PMN substance meets the concern criteria at Sec.  
721.170(b)(4)(ii).
Recommended testing: EPA has determined that an algal toxicity test 
(OPPTS 850.5400 test guideline (public draft)), a daphnid acute 
toxicity test (OPPTS 850.1010 test guideline (public draft)), and a 
fish acute toxicity test (OPPTS 850.1075 test guideline (public draft)) 
would help characterize the environmental effects of the PMN substance.
CFR citation: 40 CFR 721.10047.
PMN Number P-02-869
Chemical name: Substituted anthraquinone (generic).
CAS number: Not available.
Basis for action: The PMN states that the substance will be used as a 
site limited intermediate. Based on structural analogy to phenols, EPA 
is concerned that chronic toxicity to aquatic organisms may occur at 
concentrations above 1 ppb of the PMN substance in surface waters. As 
described in the PMN, releases of the substance are not expected to 
result in surface water concentrations above 1 ppb. Therefore, EPA has 
not determined that the proposed manufacturing, processing, or use of 
the substance may present an unreasonable risk. EPA has determined, 
however, that a manufacture/importation volume greater than 4,500 
kilograms/year may result in significant adverse environmental effects. 
Based on this information, the PMN substance meets the concern criteria 
at Sec.  721.170(b)(4)(ii).
Recommended testing: EPA has determined that a fish early life stage 
test (OPPTS 850.1400 test guideline (public draft)), a daphnid chronic 
toxicity test (OPPTS 850.1300 test guideline (public draft)), and an 
algal toxicity test (OPPTS 850.5400 test guideline (public draft)) 
would help characterize the environmental effects of the PMN substance.
CFR citation: 40 CFR 721.10048.

[[Page 14693]]

PMN Number P-02-912
Chemical name: Phenol, 4,4'-cyclohexylidenebis[2-methyl-.
CAS number: 2362-14-3.
Basis for action: The PMN states that the substance will be used as a 
raw material. Based on structural analogy to phenols, EPA is concerned 
that chronic toxicity to aquatic organisms may occur at concentrations 
as low as 1 ppb of the PMN substance in surface waters. As described in 
the PMN, the substance is not released to surface water. Therefore, EPA 
has not determined that the proposed manufacturing, processing, or use 
of the substance may present an unreasonable risk. EPA has determined, 
however, that any release of the PMN substance to surface water may 
cause significant adverse environmental effects. Based on this 
information, the PMN substance meets the concern criteria at Sec.  
721.170(b)(4)(ii).
Recommended testing: EPA has determined that a fish early-life stage 
toxicity test (OPPTS 850.1400 test guideline (public draft)) and a 
daphnid chronic toxicity test (OPPTS 850.1300 test guideline (public 
draft)) would help characterize the environmental effects of the PMN 
substance.
CFR citation: 40 CFR 721.10049.
PMN Number P-02-929
Chemical name: Disubstituted-N'- hydroxy-benzenecarboximidamide 
(generic).
CAS number: Not available.
Basis for action: The PMN states that the substance will be used as an 
intermediate. EPA has concerns for chronic toxicity to blood, kidney, 
and liver based on a submitted 28-day study. As described in the PMN, 
significant worker exposure is unlikely. Therefore, EPA has not 
determined that the proposed manufacturing, processing, or use of the 
substance may present an unreasonable risk. EPA determined, however, 
that use of the substance other than as an intermediate may result in 
exposures which may cause serious health effects. Based on this 
information, the PMN substance meets the concern criteria at Sec.  
721.170(b)(3)(i).
Recommended testing: EPA has determined that a 90-day oral toxicity 
study in rodents by the gavage route (OPPTS 870.3100 test guideline) 
would help characterize the human health effects of the PMN substance.
CFR citation: 40 CFR 721.10050.
PMN Number P-02-961
Chemical name: Spiro naphthoxazine (generic).
CAS number: Not available.
Basis for action: The PMN states that the generic (non-confidential) 
use of the substance will be as a colorant. Based on structural analogy 
to neutral organic chemicals, EPA expects chronic toxicity to aquatic 
organisms at concentrations as low as 1 ppb of the PMN substance in 
surface waters. As described in the PMN, the substance is not released 
to surface waters in significant quantities. Therefore, EPA has not 
determined that the proposed manufacturing, processing, or use of the 
substance may present an unreasonable risk. EPA has determined, 
however, that domestic manufacture of the substance could result in 
exposures which may cause significant adverse environmental effects. 
Based on this information, the PMN substance meets the concern criteria 
at Sec.  721.170(b)(4)(ii).
Recommended testing: EPA has determined that a fish early-life stage 
toxicity test (OPPTS 850.1400 test guideline (public draft)) and a 
daphnid chronic toxicity test (OPPTS 850.1300 test guideline (public 
draft)) would help characterize the environmental effects of the PMN 
substance.
CFR citation: 40 CFR 721.10051.
PMN Number P-02-1088
Chemical name: Aminoalkyl substituted alkylphenol (generic).
CAS number: Not available.
Basis for action: The PMN states that the generic (non-confidential) 
use of the substance will be in a destructive use. Based on structural 
analogy to phenols and aliphatic amines, EPA is concerned that toxicity 
to aquatic organisms may occur at concentrations as low as 1 ppb of the 
PMN substance in surface waters. As described in the PMN, the substance 
is not released to surface waters. Therefore, EPA has not determined 
that the proposed manufacturing or use of the substance may present an 
unreasonable risk. EPA has determined, however, that use of the 
substance other than as described in the PMN could result in exposures 
which may cause significant adverse environmental effects. Based on 
this information, the PMN substance meets the concern criteria at Sec.  
721.170(b)(4)(ii).
Recommended testing: EPA has determined that an algal toxicity test 
(OPPTS 850.5400 test guideline (public draft)), a daphnid acute 
toxicity test (OPPTS 850.1010 test guideline (public draft)), and a 
fish acute toxicity test (OPPTS 850.1075 test guideline (public draft)) 
would help characterize the environmental effects of the PMN substance.
CFR citation: 40 CFR 721.10052.
PMN Number P-03-41
Chemical name: Alkyl silane methacrylate (generic).
CAS number: Not available.
Basis for action: The PMN states that the generic (non-confidential) 
use of the substance will be as a chemical intermediate. Based on 
structural analogy to methacrylates and esters, EPA is concerned that 
toxicity to aquatic organisms may occur at concentrations as low as 3 
ppb of the PMN substance in surface waters. As described in the PMN, 
the substance is not released to surface waters. Therefore, EPA has not 
determined that the proposed manufacturing, processing, or use of the 
substance may present an unreasonable risk. EPA has determined, 
however, that other uses of the substance resulting in release to 
surface waters may cause significant adverse environmental effects. 
Based on this information, the PMN substance meets the concern criteria 
at Sec.  721.170(b)(4)(ii).
Recommended testing: EPA has determined that the results of a fish 
acute toxicity test (OPPTS 850.1075 test guideline (public draft)), a 
daphnid acute toxicity test (OPPTS 850.1010 test guideline (public 
draft)), and an algal toxicity test (OPPTS 850.5400 test guideline 
(public draft)) would help characterize the environmental effects of 
the PMN substance.
CFR citation: 40 CFR 721.10053.
PMN Number P-03-43
Chemical name: Phenol, polymer with formaldehyde, 3-[(2-
aminocyclohexyl)amino]-2-hydroxypropyl ethers.
CAS number: 452082-53-0.
Basis for action:The PMN states that the generic (non-confidential) use 
of the substance will be as a resin component. Based on structural 
analogy to polycationic polymers, EPA is concerned that toxicity to 
aquatic organisms may occur at concentrations as low as 20 ppb of the 
PMN substance in surface waters. As described in the PMN, the substance 
is not released to surface waters. Therefore, EPA has not determined 
that the proposed manufacturing, processing, or use of the substance 
may present an unreasonable risk. EPA has determined, however, that 
other uses of the substance resulting in release to surface waters may 
cause significant adverse environmental effects. Based on this 
information, the PMN substance meets the concern criteria at Sec.  
721.170(b)(4)(ii).
Recommended testing: EPA has determined that an algal toxicity test 
(OPPTS 850.5400 test guideline (public draft)), a daphnid acute 
toxicity test (OPPTS 850.1010 test guideline (public draft)), a fish 
acute toxicity test (OPPTS 850.1075 test guideline (public draft)), and 
a fish acute toxicity test mitigated

[[Page 14694]]

by humic acid (OPPTS 850.1085 test guideline (public draft)) would help 
characterize the environmental effects of the PMN substance.
CFR citation: 40 CFR 721.10054.
PMN Number P-03-46
Chemical name: 1-Propanaminium, 3-amino-N-(carboxymethyl)-N,N-dimethyl-
, N-soya acyl derivs., inner salts.
CAS number: 136504-87-5.
Basis for action: The PMN states that the generic (non-confidential) 
use of the substance will be as an oilfield foamer. EPA has identified 
health concerns for developmental toxicity, neurotoxicity, irritation 
and corrosion to skin and eyes, and lung effects based on analogy to 
similar quaternary compounds. As described in the PMN, significant 
inhalation exposure is unlikely. Therefore, EPA has not determined that 
the proposed manufacturing, processing, or use of the substance may 
present an unreasonable risk. EPA has determined, however, that other 
uses of the substance other than as described in the PMN may result in 
significant human exposure. Based on this information, the PMN 
substance meets the concern criteria at Sec.  721.170(b)(3)(ii).
Recommended testing: EPA has determined that a prenatal developmental 
toxicity study by the oral route in rats or rabbits (OPPTS 870.3700 
test guideline) and a repeated dose 28-day oral toxicity study in rats 
(OPPTS 870.3050 test guideline) would help characterize the human 
health effects of the PMN substance.
CFR citation: 40 CFR 721.10055.
PMN Number P-03-47
Chemical name: Benzenemethanaminium, N-(3-aminopropyl)-N,N-dimethyl-, 
N-soya acyl derivs., chlorides.
CAS number: 90194-13-1.
Basis for action: The PMN states that the generic (non-confidential) 
use of substance will be as an oilfield corrosion inhibitor. EPA has 
identified health concerns for developmental toxicity, neurotoxicity, 
lung effects, irritation to the lungs and mucous membranes, and severe 
eye irritation based on analogy to similar quaternary compounds. As 
described in the PMN, significant inhalation exposure is unlikely. 
Therefore, EPA has not determined that the proposed manufacturing, 
processing, or use of the substance may present an unreasonable risk. 
EPA has determined, however, that other uses of the substance other 
than as described in the PMN may result in significant human exposure. 
Based on this information, the PMN substance meets the concern criteria 
at Sec.  721.170(b)(3)(ii).
Recommended testing: EPA has determined that a prenatal developmental 
toxicity study by the oral route in rats or rabbits (OPPTS 870.3700 
test guideline) and a repeated dose 28-day oral toxicity study in rats 
(OPPTS 870.3050 test guideline) would help characterize the human 
health effects of the PMN substance.
CFR citation: 40 CFR 721.10056.

IV. Objectives and Rationale for this Rule

A. Rationale

    During review of the PMNs submitted for the chemical substances 
that are subject to these SNURs, EPA concluded that for 13 of the 65 
chemical substances, regulation was warranted under section 5(e) of 
TSCA, pending the development of information sufficient to make 
reasoned evaluations of the health or environmental effects of the 
chemical substances. The basis for such findings is outlined in Unit 
III. Based on these findings, TSCA section 5(e) consent orders 
requiring the use of appropriate exposure controls were negotiated with 
the PMN submitters; the SNUR provisions for these chemical substances 
listed in this document are consistent with the provisions of the TSCA 
section 5(e) consent orders.
    In the other 52 cases for which the proposed uses are not regulated 
under a TSCA section 5(e) consent order, EPA determined that one or 
more of the criteria of concern established at 40 CFR 721.170 were met, 
as discussed in Unit III.

B. Objectives

    EPA is issuing these SNURs for specific chemical substances which 
have undergone premanufacture review because the Agency wants to 
achieve the following objectives with regard to the significant new 
uses designated in this rule:
    1. EPA will receive notice of any person's intent to manufacture, 
import, or process a listed chemical substance for the described 
significant new use before that activity begins.
    2. EPA will have an opportunity to review and evaluate data 
submitted in a SNUN before the notice submitter begins manufacturing, 
importing, or processing a listed chemical substance for the described 
significant new use.
    3. EPA will be able to regulate prospective manufacturers, 
importers, or processors of a listed chemical substance before the 
described significant new use of the chemical substance occurs, 
provided that regulation is warranted pursuant to TSCA sections 5(e), 
5(f), 6 or 7.
    4. EPA will ensure that all manufacturers, importers, and 
processors of the same chemical substance that is subject to a TSCA 
section 5(e) consent order are subject to similar requirements.
    Issuance of a SNUR for a chemical substance does not signify that 
the chemical substance is listed on the TSCA Inventory. Manufacturers, 
importers, and processors are responsible for ensuring that a new 
chemical substance subject to a final SNUR is listed on the TSCA 
Inventory.

V. Direct Final Procedures

    EPA is issuing these SNURs as a direct final rule, as described in 
40 CFR 721.160(c)(3) and 721.170(d)(4). In accordance with 40 CFR 
721.160(c)(3)(ii) and 721.170(d)(4)(i), this rule will be effective May 
29, 2007, unless EPA receives a written notice by April 30, 2007 of 
adverse or critical comments, or notice of intent to submit adverse or 
critical comments, on EPA's action. If EPA receives such a notice, EPA 
will publish a document to withdraw the direct final SNUR for the 
specific chemical substance to which the adverse or critical comments 
apply. EPA will then propose a SNUR for the specific chemical substance 
providing a 30-day comment period.
    This action establishes SNURs for a number of chemical substances. 
Any person who submits adverse or critical comments or notice of intent 
to submit adverse or critical comments, must identify the chemical 
substance and the new use to which it applies. EPA will not withdraw a 
SNUR for a chemical substance not identified in a notice.

VI. Test Data and Other Information

    EPA recognizes that TSCA section 5 does not require developing any 
particular test data before submission of a SNUN. Persons are required 
only to submit test data in their possession or control and to describe 
any other data known to or reasonably ascertainable by them. However, 
upon review of PMNs and SNUNs, the Agency has the authority to require 
appropriate testing. In cases where EPA issued a TSCA section 5(e) 
consent order that requires or recommends certain testing, Unit III. 
lists those tests. Unit III. also lists recommended testing for non-
5(e) SNURs. Descriptions of recommended tests are provided for 
informational purposes. EPA strongly encourages persons, before 
performing any testing, to consult with the Agency pertaining to

[[Page 14695]]

protocol selection. Many test guidelines are now available on the 
Internet at http://www.epa.gov/opptsfrs/home/guidelin.htm.
    In the TSCA section 5(e) consent orders for several of the chemical 
substances regulated under this rule, EPA has established production 
limits in view of the lack of data on the potential health and 
environmental risks that may be posed by the significant new uses or 
increased exposure to the chemical substances. These production limits 
cannot be exceeded unless the PMN submitter first submits the results 
of toxicity tests that would permit a reasoned evaluation of the 
potential risks posed by these chemical substances. Under recent 
consent orders, each PMN submitter is required to submit each study at 
least 14 weeks (earlier consent orders required submissions at least 12 
weeks) before reaching the specified production limit. Listings of the 
tests specified in the TSCA section 5(e) consent orders are included in 
Unit III. The SNURs contain the same production volume limits as the 
consent orders. Exceeding these production limits is defined as a 
significant new use. Persons who intend to exceed the production limit 
must notify the Agency by submitting a SNUN at least 90 days in 
advance.
    The recommended tests may not be the only means of addressing the 
potential risks of the chemical substance. However, SNUNs submitted for 
significant new uses without any test data may increase the likelihood 
that EPA will take action under TSCA section 5(e), particularly if 
satisfactory test results have not been obtained from a prior 
submitter. EPA recommends that potential SNUN submitters contact EPA 
early enough so that they will be able to conduct the appropriate 
tests.
    SNUN submitters should be aware that EPA will be better able to 
evaluate SNUNs which provide detailed information on the following:
    1. Human exposure and environmental release that may result from 
the significant new use of the chemical substances.
    2. Potential benefits of the chemical substances.
    3. Information on risks posed by the chemical substances compared 
to risks posed by potential substitutes.

VII. Procedural Determinations

    EPA is establishing through this rule certain significant new uses 
which have been claimed as CBI subject to Agency confidentiality 
regulations at 40 CFR part 2. EPA is required to keep this information 
confidential to protect the CBI of the original PMN submitter. EPA 
promulgated a procedure to deal with the situation where a specific 
significant new use is CBI. This procedure appears in 40 CFR 
721.1725(b)(1) and is similar to that in Sec.  721.11 for situations 
where the chemical identity of the chemical substance subject to a SNUR 
is CBI. This procedure is cross-referenced in each of the SNURs that 
include specific significant new uses that are CBI.
    A manufacturer or importer may request EPA to determine whether a 
proposed use would be a significant new use under this rule. Under the 
procedure in Sec.  721.1725(b)(1), a manufacturer or importer must show 
that it has a bona fide intent to manufacture or import the chemical 
substance and must identify the specific use for which it intends to 
manufacture or import the chemical substance. If EPA concludes that the 
person has shown a bona fide intent to manufacture or import the 
chemical substance, EPA will tell the person whether the use identified 
in the bona fide submission would be a significant new use under the 
rule. Since most of the chemical identities of the chemical substances 
subject to these SNURs are also CBI, manufacturers and processors can 
combine the bona fide submission under the procedure in Sec.  
721.1725(b)(1) with that under Sec.  721.11 into a single step.
    If a manufacturer or importer is told that the production volume 
identified in the bona fide submission would not be a significant new 
use, i.e., it is below the level that would be a significant new use, 
that person can manufacture or import the chemical substance as long as 
the aggregate amount does not exceed that identified in the bona fide 
submission to EPA. If the person later intends to exceed that volume, a 
new bona fide submission would be necessary to determine whether that 
higher volume would be a significant new use. EPA is considering 
whether to adopt a special procedure for use when CBI production volume 
is designated as a significant new use. Under such a procedure, a 
person showing a bona fide intent to manufacture or import the chemical 
substance, under the procedure described in Sec.  721.11, would 
automatically be informed of the production volume that would be a 
significant new use. Thus, the person would not have to make multiple 
bona fide submissions to EPA for the same chemical substance to remain 
in compliance with the SNUR, as could be the case under the procedures 
in Sec.  721.1725(b)(1).

VIII. Applicability of Rule to Uses Occurring Before Effective Date of 
the Final Rule

    To establish a significant ``new'' use, EPA must determine that the 
use is not ongoing. The chemical substances subject to this rule have 
recently undergone premanufacture review. TSCA section 5(e) consent 
orders have been issued for 13 chemical substances and notice 
submitters are prohibited by the TSCA section 5(e) consent orders from 
undertaking activities which EPA is designating as significant new 
uses. In cases where EPA has not received a notice of commencement 
(NOC) and the chemical substance has not been added to the TSCA 
Inventory, no other person may commence such activities without first 
submitting a PMN. For chemical substances for which an NOC has not been 
submitted at this time, EPA has concluded that the uses are not 
ongoing. However, EPA recognizes in cases when chemical substances 
identified in this SNUR are added to the TSCA Inventory prior to the 
effective date of the rule, the chemical substances may be 
manufactured, imported, or processed by other persons for a significant 
new use as defined in this rule before the effective date of the rule. 
However, 35 of the 65 chemical substances contained in this rule have 
CBI chemical identities, and since EPA has received a limited number of 
post-PMN bona fide submissions (per 40 CFR 720.25 and 721.11), the 
Agency believes that it is highly unlikely that any of the significant 
new uses described in the following regulatory text are ongoing. EPA 
solicits comments on whether any of the uses described as significant 
new uses are ongoing.
    As discussed in the Federal Register of April 24, 1990 (55 FR 
17376), EPA has decided that the intent of section 5(a)(1)(B) of TSCA 
is best served by designating a use as a significant new use as of the 
date of publication of this direct final rule rather than as of the 
effective date of the rule. If uses begun after publication were 
considered ongoing rather than new, it would be difficult for EPA to 
establish SNUR notice requirements because a person could defeat the 
SNUR by initiating the significant new use before the rule became 
final, and then argue that the use was ongoing as of the effective date 
of the final rule. Thus, persons who begin commercial manufacture, 
import, or processing of the chemical substances regulated through this 
SNUR will have to cease any such activity before the effective date of 
this rule. To resume their activities, these persons would have to 
comply with all applicable

[[Page 14696]]

SNUR notice requirements and wait until the notice review period, 
including all extensions, expires. EPA has promulgated provisions to 
allow persons to comply with this SNUR before the effective date. If a 
person were to meet the conditions of advance compliance under Sec.  
721.45(h), the person would be considered to have met the requirements 
of the final SNUR for those activities.

IX. SNUN Submissions

    EPA recommends that submitters consult with the Agency prior to 
submitting a SNUN to discuss what data may be useful in evaluating a 
significant new use. Discussions with the Agency prior to submission 
can afford submitters ample time to conduct any tests that might be 
helpful in evaluating risks posed by the substance. According to 40 CFR 
721.1(c), persons submitting a SNUN must comply with the same notice 
requirements and EPA regulatory procedures as persons submitting a PMN, 
including submission of test data on health and environmental effects 
as described in 40 CFR 720.50.
    SNUNs must be mailed to the Environmental Protection Agency, OPPT 
Document Control Office (7407M), 1200 Pennsylvania Ave., NW., 
Washington, DC 20460-0001. Information must be submitted in the form 
and manner set forth in EPA Form No. 7710-25. This form is available 
from the Environmental Assistance Division (7408M), 1200 Pennsylvania 
Ave., NW., Washington, DC 20460-0001 (see 40 CFR 721.25 and 720.40). 
Forms and information are also available electronically at http://www.epa.gov/opptintr/newchems/pubs/pmnforms.htm.

X. Notification on Substances for Which Significant New Use Rules are 
Not Being Issued

    As required in 40 CFR 721.160(a)(2), EPA is providing notification 
on the following two chemical substances that are subject to final TSCA 
section 5(e) consent orders but for which EPA has decided not to issue 
significant new use rules at this time. EPA is not publishing SNURs for 
PMNs P-02-193 and P-03-394 because they are subject to exposure-based 
consent orders. EPA's exposure-based policies for new chemical 
substances are based on TSCA section 5(e)(1)(A)(ii)(II) and are 
described on the New Chemicals website at http://www.epa.gov/oppt/newchems/pubs/expbased.htm. Exposure-based consent orders are based on 
two findings: 1) Insufficient information available on the health and 
environmental effects of the PMN substance, and 2) expected substantial 
production volume and significant or substantial human exposure and/or 
release to the environment. Exposure-based consent orders prohibit the 
submitter from exceeding a specific, aggregate production or import 
volume unless the submitter has conducted the fate, aquatic toxicity, 
and/or health effects testing specified in the order and submitted the 
results to EPA. The production or import volume limit is usually set so 
that it will occur within a few years. Therefore, instead of publishing 
and often revoking exposure-based SNURs within a short timespan, EPA 
generally defers publication of SNURs on substances subject to 
exposure-based consent orders until the test data are received. In many 
cases, data received through an exposure-based consent order confirm 
the Agency's prediction of low or no risk, so no further regulatory 
action is warranted.

XI. Economic Analysis

    EPA has evaluated the potential costs of establishing SNUN 
requirements for potential manufacturers, importers, and processors of 
the chemical substances subject to this rule. EPA's complete economic 
analysis is available in the public docket.

XII. Statutory and Executive Order Reviews

1. Executive Order 12866: Regulatory Planning and Review

    Under Executive Order 12866, entitled Regulatory Planning and 
Review (58 FR 51735, October 4, 1993), the Office of Management and 
Budget (OMB) has determined that a proposed or final SNUR is not a 
``significant regulatory action'' subject to review by OMB, because it 
does not meet the criteria in section 3(f) of the Executive order.

2. Paperwork Reduction Act

    According to the Paperwork Reduction Act (PRA), 44 U.S.C. 3501 et 
seq., an Agency may not conduct or sponsor, and a person is not 
required to respond to a collection of information that requires OMB 
approval under the PRA, unless it has been approved by OMB and displays 
a currently valid OMB control number. The OMB control numbers for EPA's 
regulations in title 40 of the CFR, after appearing in the Federal 
Register, are listed in 40 CFR part 9, and included on the related 
collection instrument or form, if applicable.
    The information collection requirements related to this action have 
already been approved by OMB pursuant to the PRA under OMB control 
number 2070-0012 (EPA ICR No. 574). This action does not impose any 
burden requiring additional OMB approval. If an entity were to submit a 
SNUN to the Agency, the annual burden is estimated to average between 
30 and 170 hours per response. This burden estimate includes the time 
needed to review instructions, search existing data sources, gather and 
maintain the data needed, and complete, review, and submit the required 
SNUN.
    Send any comments about the accuracy of the burden estimate, and 
any suggested methods for minimizing respondent burden, including 
through the use of automated collection techniques, to the Director, 
Collection Strategies Division, Office of Environmental Information 
(2822T), Environmental Protection Agency, 1200 Pennsylvania Ave., NW., 
Washington, DC 20460-0001. Please remember to include the OMB control 
number in any correspondence, but do not submit any completed forms to 
this address.

3. Regulatory Flexibility Act

    Pursuant to section 605(b) of the Regulatory Flexibility Act (RFA) 
(5 U.S.C. 601 et seq.), the Agency hereby certifies that promulgation 
of this SNUR will not have a significant adverse economic impact on a 
substantial number of small entities. The rationale supporting this 
conclusion is as follows. A SNUR applies to any person (including small 
or large entities) who intends to engage in any activity described in 
the rule as a ``significant new use.'' By definition of the word 
``new,'' and based on all information currently available to EPA, it 
appears that no small or large entities presently engage in such 
activity. Since a SNUR only requires that any person who intends to 
engage in such activity in the future must first notify EPA by 
submitting a SNUN, no economic impact will even occur until someone 
decides to engage in those activities. Although some small entities may 
decide to conduct such activities in the future, EPA cannot presently 
determine how many, if any, there may be. However, EPA's experience to 
date is that, in response to the promulgation of over 1,000 SNURs, the 
Agency receives on average only 10 notices per year. Of those SNUNs 
submitted, none appear to be from small entities in response to any 
SNUR. In addition, the estimated reporting cost for submission of a 
SNUN (see Unit IX.), is minimal regardless of the size of the firm. 
Therefore, EPA believes that the potential economic impact of complying 
with this SNUR is

[[Page 14697]]

not expected to be significant or adversely impact a substantial number 
of small entities. In a SNUR that published on June 2, 1997 (62 FR 
29684) (FRL-5597-1), the Agency presented it's general determination 
that proposed and final SNURs are not expected to have a significant 
economic impact on a substantial number of small entities, which was 
provided to the Chief Counsel for Advocacy of the Small Business 
Administration.

4. Unfunded Mandates Reform Act

    Based on EPA's experience with proposing and finalizing SNURs, 
State, local, and Tribal governments have not been impacted by these 
rulemakings, and EPA does not have any reason to believe that any 
State, local, or Tribal government will be impacted by this rulemaking. 
As such, EPA has determined that this regulatory action does not impose 
any enforceable duty, contain any unfunded mandate, or otherwise have 
any affect on small governments subject to the requirements of sections 
202, 203, 204, or 205 of the Unfunded Mandates Reform Act of 1995 
(UMRA) (Public Law 104-4).

5. Executive Order 13132: Federalism

    This action will not have a substantial direct effect on States, on 
the relationship between the national government and the States, or on 
the distribution of power and responsibilities among the various levels 
of government, as specified in Executive Order 13132, entitled 
Federalism (64 FR 43255, August 10, 1999).

6. Executive Order 13175: Consultation and Coordination with Indian 
Tribal Governments

    This rule does not have Tribal implications because it is not 
expected to have substantial direct effects on Indian Tribes. This does 
not significantly or uniquely affect the communities of Indian Tribal 
governments, nor does it involve or impose any requirements that affect 
Indian Tribes. Accordingly, the requirements of Executive Order 13175, 
entitled Consultation and Coordination with Indian Tribal Governments 
(65 FR 67249, November 6, 2000), do not apply to this rule.

7. Executive Order 13045: Protection of Children from Environmental 
Health Risks and Safety Risks

    This action is not subject to Executive Order 13045, entitled 
Protection of Children from Environmental Health Risks and Safety Risks 
(62 FR 19885, April 23, 1997), because this is not an economically 
significant regulatory action as defined by Executive Order 12866, and 
this action does not address environmental health or safety risks 
disproportionately affecting children.

8. Executive Order 13211: Actions that Significantly Affect Energy 
Supply, Distribution, or Use

    This rule is not subject to Executive Order 13211, entitled Actions 
Concerning Regulations That Significantly Affect Energy Supply, 
Distribution, or Use (66 FR 28355, May 22, 2001), because this action 
is not expected to affect energy supply, distribution, or use.

9. National Technology Transfer Advancement Act

    In addition, since this action does not involve any technical 
standards, section 12(d) of the National Technology Transfer and 
Advancement Act of 1995 (NTTAA), Public Law 104-113, section 12(d) (15 
U.S.C. 272 note), does not apply to this action.

10. Executive Order 12898: Federal Actions to Address Environmental 
Justice in Minority Populations and Low-Income Populations

    This action does not entail special considerations of environmental 
justice related issues as delineated by Executive Order 12898, entitled 
Federal Actions to Address Environmental Justice in Minority 
Populations and Low-Income Populations (59 FR 7629, February 16, 1994).

11. Executive Order 12630: Governmental Actions and Interference with 
Constitutionally Protected Property Rights (Takings)

    EPA has complied with Executive Order 12630, entitled Governmental 
Actions and Interference with Constitutionally Protected Property 
Rights (53 FR 8859, March 15, 1988), by examining the takings 
implications of this rule in accordance with the ``Attorney General's 
Supplemental Guidelines for the Evaluation of Risk and Avoidance of 
Unanticipated Takings'' issued under the Executive order.

12. Executive Order 12988: Civil Justice Reform

    In issuing this rule, EPA has taken the necessary steps to 
eliminate drafting errors and ambiguity, minimize potential litigation, 
and provide a clear legal standard for affected conduct, as required by 
section 3 of Executive Order 12988, entitled Civil Justice Reform (61 
FR 4729, February 7, 1996).

13. Congressional Review Act

    The Congressional Review Act, 5 U.S.C. 801 et seq., generally 
provides that before a final rule may take effect, the Agency 
promulgating the final rule must submit a final rule report to each 
House of the Congress and to the Comptroller General of the United 
States. EPA will submit a report containing this final rule and other 
required information to the U.S. Senate, the U.S. House of 
Representatives, and the Comptroller General of the United States prior 
to publication of this final rule in the Federal Register. This final 
rule is not a ``major rule'' as defined by 5 U.S.C. 804(2).

List of Subjects in 40 CFR Part 721

    Environmental protection, Chemicals, Hazardous substances, 
Reporting and recordkeeping requirements.


    Dated: March 22, 2007.
Charles M. Auer,
Director, Office of Pollution Prevention and Toxics.

0
Therefore, 40 CFR part 721 is amended as follows:

PART 721--[AMENDED]

0
1. The authority citation for part 721 continues to read as follows:

    Authority: 15 U.S.C. 2604, 2607, and 2625(c).

0
2. By adding new Sec.  721.10002 to subpart E to read as follows:


Sec.  721.10002  2-Thiazolidinone.

    (a) Chemical substance and significant new uses subject to 
reporting. (1) The chemical substance identified as 2-thiazolidinone 
(PMN P-97-415; CAS No. 2682-49-7) is subject to reporting under this 
section for the significant new uses described in paragraph (a)(2) of 
this section.
    (2) The significant new uses are:
    (i) Protection in the workplace. Requirements as specified in Sec.  
721.63 (a)(1), (a)(3), (a)(4), (a)(6)(i), (b), and (c). The following 
National Institute for Occupational Safety and Health (NIOSH)-approved 
respirators with an assigned protection factor (APF) of 10-25 meet the 
minimum requirements for Sec.  721.63(a)(4): Air-purifying, tight-
fitting respirator (either half- or full-face) equipped with N100 (if 
aerosols absent), R100, or P100 filters; powered air-purifying 
respirator equipped with a loose-fitting hood or helmet and High 
Efficiency Particulate Air (HEPA) filters; powered air-purifying 
respirator equipped with a tight-fitting facepiece (either half- or 
full-face) and HEPA filters; and supplied-air respirator operated in 
pressure demand or

[[Page 14698]]

continuous flow mode and equipped with a hood or helmet or tight-
fitting facepiece (either half- or full-face). As an alternative to the 
respiratory requirements listed here, a manufacturer, importer, or 
processor may choose to follow the new chemical exposure limit (NCEL) 
provisions listed in the TSCA section 5(e) consent order for this 
substance. The NCEL is 0.7 mg/m\3\ as an 8-hour time-weighted average. 
Persons who wish to pursue NCELs as an alternative to the Sec.  721.63 
respirator requirements may request to do so under 40 CFR 721.30. 
Persons whose Sec.  721.30 requests to use the NCELs approach are 
approved by EPA will receive NCELs provisions comparable to those 
contained in the corresponding section 5(e) consent order.
    (ii) Hazard communication program. Requirements as specified in 
Sec.  721.72 (a), (b), (c), (d), (e) (concentration set at 1.0 
percent), (f), (g)(1)(iii), (g)(1)(iv), (g)(1)(vi), (g)(1)(ix), 
(g)(2)(i), (g)(2)(ii), (g)(2)(iii), (g)(2)(iv) (use respiratory 
protection or maintain workplace airborne concentrations at or below an 
8-hour time-weighted average of 0.7 mg/m\3\), (g)(2)(v), (g)(3)(ii), 
(g)(4)(i), (g)(4)(ii), (g)(4)(iii), and (g)(5). The following statement 
shall appear on each label as specified in Sec.  721.72(b) and the 
Material Safety Data Sheet (MSDS) as specified in Sec.  721.72(c). The 
substance may cause severe eye irritation. The substance may cause 
internal organ effects (blood, liver, and kidney). The substance may 
cause developmental/maternal effects. When handling this substance as a 
powder, use respiratory protection.
    (iii) Industrial, commercial, and consumer activities. Requirements 
as specified in Sec.  721.80 (g), (p) (300,000 kilograms), (v)(1), 
(w)(1), and (x)(1).
    (iv) Disposal. Requirements as specified in Sec.  721.85 (a)(1), 
(a)(2), (a)(3), (b)(1), (b)(2), (b)(3), (c)(1), (c)(2), and (c)(3).
    (v) Release to water. Requirements as specified in Sec.  721.90 
(a)(1), (b)(1), and (c)(1).
    (b) Specific requirements. The provisions of subpart A of this part 
apply to this section except as modified by this paragraph.
    (1) Recordkeeping. Recordkeeping requirements as specified in Sec.  
721.125 (a), (b), (c), (d), (e), (f), (g), (h), (i), (j), and (k) are 
applicable to manufacturers, importers, and processors of this 
substance.
    (2) Limitations or revocation of certain notification requirements. 
The provisions of Sec.  721.185 apply to this section.

0
3. By adding new Sec.  721.10003 to subpart E to read as follows:


Sec.  721.10003  Manganese heterocyclic tetraamine complex (generic).

    (a) Chemical substances and significant new uses subject to 
reporting. (1) The chemical substances identified generically as 
manganese heterocyclic tetraamine complex (PMNs P-98-625/626/627/628/
629 and P-00-614/617) are subject to reporting under this section for 
the significant new uses described in paragraph (a)(2) of this section.
    (2) The significant new uses are:
    (i) Industrial, commercial, and consumer activities. Requirements 
as specified in Sec.  721.80(s) (10,000 kilograms per chemical 
substance).
    (ii) [Reserved]
    (b) Specific requirements. The provisions of subpart A of this part 
apply to this section except as modified by this paragraph.
    (1) Recordkeeping. Recordkeeping requirements as specified in Sec.  
721.125 (a), (b), (c), and (i) are applicable to manufacturers, 
importers, and processors of this substance.
    (2) Limitations or revocation of certain notification requirements. 
The provisions of Sec.  721.185 apply to this section.

0
4. By adding new Sec.  721.10004 to subpart E to read as follows:


Sec.  721.10004  2-Butenoic acid, 4,4'-
[(dibutylstannylene)bis(oxy)]bis[4-oxo-, (2Z,2'Z)-, di-
C<INF>8-10</INF>-isoalkyl esters, C<INF>9</INF>-rich.

    (a) Chemical substance and significant new uses subject to 
reporting. (1) The chemical substance identified as 2-butenoic acid, 
4,4'-[(dibutylstannylene)bis(oxy)]bis[4-oxo-, (2Z,2'Z)-, di-
C<INF>8-10</INF>-isoalkyl esters, C<INF>9</INF>-rich (PMN P-98-1181; 
CAS No. 247041-56-1) is subject to reporting under this section for the 
significant new uses described in paragraph (a)(2) of this section.
    (2) The significant new uses are:
    (i) Protection in the workplace. Requirements as specified in Sec.  
721.63 (a)(1), (a)(2)(i), and (a)(3).
    (ii) Industrial, commercial, and consumer activities. Requirements 
as specified in Sec.  721.80 (v)(2), (w)(2), (x)(2), and (y)(1).
    (b) Specific requirements. The provisions of subpart A of this part 
apply to this section except as modified by this paragraph.
    (1) Recordkeeping. Recordkeeping requirements as specified in Sec.  
721.125 (a), (b), (c), (d), (e), and (i) are applicable to 
manufacturers, importers, and processors of this substance.
    (2) Limitations or revocation of certain notification requirements. 
The provisions of Sec.  721.185 apply to this section.

0
5. By adding new Sec.  721.10005 to subpart E to read as follows:


Sec.  721.10005  2-Butenoic acid, 4,4'-[(dibutylstannylene)bis(oxy)]bis 
[4-oxo-, (2Z,2'Z)-, di-C<INF>9-11</INF>-isoalkyl esters, 
C<INF>10</INF>-rich.

    (a) Chemical substance and significant new uses subject to 
reporting. (1) The chemical substance identified as 2-butenoic acid, 4 
,4'-[(dibutylstannylene)bis(oxy)]bis [4-oxo-, (2Z,2'Z)-, di-
C<INF>9-11</INF>-isoalkyl esters, C<INF>10</INF>-rich (PMN P-98-1182) 
is subject to reporting under this section for the significant new uses 
described in paragraph (a)(2) of this section.
    (2) The significant new uses are:
    (i) Protection in the workplace. Requirements as specified in Sec.  
721.63 (a)(1), (a)(2)(i), and (a)(3).
    (ii) Industrial, commercial, and consumer activities. Requirements 
as specified in Sec.  721.80 (v)(2), (w)(2), (x)(2), and (y)(1).
    (b) Specific requirements. The provisions of subpart A of this part 
apply to this section except as modified by this paragraph.
    (1) Recordkeeping. Recordkeeping requirements as specified in Sec.  
721.125 (a), (b), (c), (d), (e), and (i) are applicable to 
manufacturers, importers, and processors of this substance.
    (2) Limitations or revocation of certain notification requirements. 
The provisions of Sec.  721.185 apply to this section.

0
6. By adding new Sec.  721.10006 to subpart E to read as follows:


Sec.  721.10006  Mixed metal oxide (generic).

    (a) Chemical substance and significant new uses subject to 
reporting. (1) The chemical substance identified generically as mixed 
metal oxide (PMN P-99-511) is subject to reporting under this section 
for the significant new uses described in paragraph (a)(2) of this 
section.
    (2) The significant new uses are:
    (i) Industrial, commercial, and consumer activities. Requirements 
as specified in Sec.  721.80(s) (60,000 kilograms).
    (ii) [Reserved]
    (b) Specific requirements. The provisions of subpart A of this part 
apply to this section except as modified by this paragraph.
    (1) Recordkeeping. Recordkeeping requirements as specified in Sec.  
721.125 (a), (b), (c), and (i) are applicable to manufacturers, 
importers, and processors of this substance.
    (2) Limitations or revocation of certain notification requirements. 
The provisions of Sec.  721.185 apply to this section.

0
7. By adding new Sec.  721.10007 to subpart E to read as follows:

[[Page 14699]]

Sec.  721.10007  Alcohols, C<INF>12-14</INF>- secondary, ethoxylated 
propoxylated.

    (a) Chemical substance and significant new uses subject to 
reporting. (1) The chemical substance identified as alcohols, 
C<INF>12-14</INF>- secondary, ethoxylated propoxylated (PMN P-00-11; 
CAS No. 103331-86-8) is subject to reporting under this section for the 
significant new uses described in paragraph (a)(2) of this section.
    (2) The significant new uses are:
    (i) Release to water. Requirements as specified in Sec.  721.90 
(a)(4), (b)(4), and (c)(4) (N = 50).
    (ii) [Reserved]
    (b) Specific requirements. The provisions of subpart A of this part 
apply to this section except as modified by this paragraph.
    (1) Recordkeeping. Recordkeeping requirements as specified in Sec.  
721.125 (a), (b), (c), and (k) are applicable to manufacturers, 
importers, and processors of this substance.
    (2) Limitations or revocation of certain notification requirements. 
The provisions of Sec.  721.185 apply to this section.

0
8. By adding new Sec.  721.10008 to subpart E to read as follows:


Sec.  721.10008  Manganese strontium oxide (MnSrO<INF>3</INF>).

    (a) Chemical substance and significant new uses subject to 
reporting. (1) The chemical substance identified as manganese strontium 
oxide (MnSrO<INF>3</INF>) (PMN P-00-1121; CAS No. 12163-45-0) is 
subject to reporting under this section for the significant new uses 
described in paragraph (a)(2) of this section.
    (2) The significant new uses are:
    (i) Hazard communication program. Requirements as specified in 
Sec.  721.72 (a), (b), (c), (d), (e) (concentration set at 0.1 
percent), (f), (g)(1)(i), (g)(1)(ii), (g)(1)(iii), (g)(1)(vii), 
(g)(1)(viii), (g)(2)(i), (g)(2)(ii), (g)(2)(iii), (g)(2)(v), 
(g)(3)(ii), (g)(4)(i), and (g)(5).
    (ii) Industrial, commercial, and consumer activities. Requirements 
as specified in Sec.  721.80 (k) (manufacture, processing, or use of 
the PMN substance if the particle size is less than 10 microns) and 
(q).
    (iii) Release to water. Requirements as specified in Sec.  721.90 
(a)(4), (b)(4), and (c)(4) (N=1).
    (b) Specific requirements. The provisions of subpart A of this part 
apply to this section except as modified by this paragraph.
    (1) Recordkeeping. Recordkeeping requirements as specified in Sec.  
721.125 (a), (b), (c), (f), (g), (h), (i), and (k) are applicable to 
manufacturers, importers, and processors of this substance.
    (2) Limitations or revocation of certain notification requirements. 
The provisions of Sec.  721.185 apply to this section.
    (3) Determining whether a specific use is subject to this section. 
The provisions of Sec.  721.1725(b)(1) apply to this section.

0
9. By adding new Sec.  721.10009 to subpart E to read as follows:


Sec.  721.10009  Manganese yttrium oxide (MnYO<INF>3</INF>).

    (a) Chemical substance and significant new uses subject to 
reporting. (1) The chemical substance identified as manganese yttrium 
oxide (MnYO<INF>3</INF>) (PMN P-00-1122; CAS No. 12032-75-6) is subject 
to reporting under this section for the significant new uses described 
in paragraph (a)(2) of this section.
    (2) The significant new uses are:
    (i) Hazard communication program. Requirements as specified in 
Sec.  721.72 (a), (b), (c), (d), (e) (concentration set at 0.1 
percent), (f), (g)(1)(i), (g)(1)(ii), (g)(1)(iii), (g)(1)(vii), 
(g)(1)(viii), (g)(2)(i), (g)(2)(ii), (g)(2)(iii), (g)(2)(v), 
(g)(3)(ii), (g)(4)(i), and (g)(5).
    (ii) Industrial, commercial, and consumer activities. Requirements 
as specified in Sec.  721.80 (k) (manufacture, processing, or use of 
the PMN substance if the particle size is less than 10 microns) and 
(q).
    (iii) Release to water. Requirements as specified in Sec.  721.90 
(a)(4), (b)(4), and (c)(4) (N=1).
    (b) Specific requirements. The provisions of subpart A of this part 
apply to this section except as modified by this paragraph.
    (1) Recordkeeping. Recordkeeping requirements as specified in Sec.  
721.125 (a), (b), (c), (f), (g), (h), (i), and (k) are applicable to 
manufacturers, importers, and processors of this substance.
    (2) Limitations or revocation of certain notification requirements. 
The provisions of Sec.  721.185 apply to this section.
    (3) Determining whether a specific use is subject to this section. 
The provisions of Sec.  721.1725(b)(1) apply to this section.

0
10. By adding new Sec.  721.10010 to subpart E to read as follows:


Sec.  721.10010  Barium manganese oxide (BaMnO<INF>3</INF>).

    (a) Chemical substance and significant new uses subject to 
reporting. (1) The chemical substance identified as barium manganese 
oxide (BaMnO<INF>3</INF>) (PMN P-00-1123; CAS No. 12230-80-7) is 
subject to reporting under this section for the significant new uses 
described in paragraph (a)(2) of this section.
    (2) The significant new uses are:
    (i) Hazard communication program. Requirements as specified in 
Sec.  721.72 (a), (b), (c), (d), (e) (concentration set at 0.1 
percent), (f), (g)(1)(i), (g)(1)(ii), (g)(1)(iii), (g)(1)(vii), 
(g)(1)(viii), (g)(2)(i), (g)(2)(ii), (g)(2)(iii), (g)(2)(v), 
(g)(3)(ii), (g)(4)(i), and (g)(5).
    (ii) Industrial, commercial, and consumer activities. Requirements 
as specified in Sec.  721.80 (k) (manufacture, processing, or use of 
the PMN substance if the particle size is less than 10 microns) and 
(q).
    (iii) Release to water. Requirements as specified in Sec.  721.90 
(a)(4), (b)(4), and (c)(4) (N=1).
    (b) Specific requirements. The provisions of subpart A of this part 
apply to this section except as modified by this paragraph.
    (1) Recordkeeping. Recordkeeping requirements as specified in Sec.  
721.125 (a), (b), (c), (f), (g), (h), (i), and (k) are applicable to 
manufacturers, importers, and processors of this substance.
    (2) Limitations or revocation of certain notification requirements. 
The provisions of Sec.  721.185 apply to this section.
    (3) Determining whether a specific use is subject to this section. 
The provisions of Sec.  721.1725(b)(1) apply to this section.

0
11. By adding new Sec.  721.10011 to subpart E to read as follows:


Sec.  721.10011  Barium calcium manganese strontium oxide.

    (a) Chemical substance and significant new uses subject to 
reporting. (1) The chemical substance identified as barium calcium 
manganese strontium oxide (PMN P-00-1124; CAS No. 359427-90-0) is 
subject to reporting under this section for the significant new uses 
described in paragraph (a)(2) of this section.
    (2) The significant new uses are:
    (i) Hazard communication program. Requirements as specified in 
Sec.  721.72 (a), (b), (c), (d), (e) (concentration set at 0.1 
percent), (f), (g)(1)(i), (g)(1)(ii), (g)(1)(iii), (g)(1)(vii), 
(g)(1)(viii), (g)(2)(i), (g)(2)(ii), (g)(2)(iii), (g)(2)(v), 
(g)(3)(ii), (g)(4)(i), and (g)(5).
    (ii) Industrial, commercial, and consumer activities. Requirements 
as specified in Sec.  721.80 (k) (manufacture, processing, or use of 
the PMN substance if the particle size is less than 10 microns) and 
(q).
    (iii) Release to water. Requirements as specified in Sec.  721.90 
(a)(4), (b)(4), and (c)(4) (N=1).
    (b) Specific requirements. The provisions of subpart A of this part 
apply to this section except as modified by this paragraph.
    (1) Recordkeeping. Recordkeeping requirements as specified in Sec.  
721.125 (a), (b), (c), (f), (g), (h), (i), and (k) are applicable to 
manufacturers, importers, and processors of this substance.
    (2) Limitations or revocation of certain notification requirements. 
The

[[Page 14700]]

provisions of Sec.  721.185 apply to this section.
    (3) Determining whether a specific use is subject to this section. 
The provisions of Sec.  721.1725(b)(1) apply to this section.

0
12. By adding new Sec.  721.10012 to subpart E to read as follows:


Sec.  721.10012  Manganate (MnO<INF>2</INF>\1\<SUP>-</SUP>), calcium 
(2:1).

    (a) Chemical substance and significant new uses subject to 
reporting. (1) The chemical substance identified as manganate 
(MnO<INF>2</INF>\1\<SUP>-</SUP>), calcium (2:1) (PMN P-00-1125; CAS No. 
12049-47-7) is subject to reporting under this section for the 
significant new uses described in paragraph (a)(2) of this section.
    (2) The significant new uses are:
    (i) Hazard communication program. Requirements as specified in 
Sec.  721.72 (a), (b), (c), (d), (e) (concentration set at 0.1 
percent), (f), (g)(1)(i), (g)(1)(ii), (g)(1)(iii), (g)(1)(vii), 
(g)(1)(viii), (g)(2)(i), (g)(2)(ii), (g)(2)(iii), (g)(2)(v), 
(g)(3)(ii), (g)(4)(i), and (g)(5).
    (ii) Industrial, commercial, and consumer activities. Requirements 
as specified in Sec.  721.80 (k) (manufacture, processing, or use of 
the PMN substance if the particle size is less than 10 microns) and 
(q).
    (iii) Release to water. Requirements as specified in Sec.  721.90 
(a)(4), (b)(4), and (c)(4) (N=1).
    (b) Specific requirements. The provisions of subpart A of this part 
apply to this section except as modified by this paragraph.
    (1) Recordkeeping. Recordkeeping requirements as specified in Sec.  
721.125 (a), (b), (c), (f), (g), (h), (i), and (k) are applicable to 
manufacturers, importers, and processors of this substance.
    (2) Limitations or revocation of certain notification requirements. 
The provisions of Sec.  721.185 apply to this section.
    (3) Determining whether a specific use is subject to this section. 
The provisions of Sec.  721.1725(b)(1) apply to this section.

0
13. By adding new Sec.  721.10013 to subpart E to read as follows:


Sec.  721.10013  Manganese yttrium oxide 
(Mn<INF>2</INF>YO<INF>5</INF>).

    (a) Chemical substance and significant new uses subject to 
reporting. (1) The chemical substance identified as manganese yttrium 
oxide (Mn<INF>2</INF>YO<INF>5</INF>) (PMN P-00-1126; CAS No. 12438-71-
0) is subject to reporting under this section for the significant new 
uses described in paragraph (a)(2) of this section.
    (2) The significant new uses are:
    (i) Hazard communication program. Requirements as specified in 
Sec.  721.72 (a), (b), (c), (d), (e) (concentration set at 0.1 
percent), (f), (g)(1)(i), (g)(1)(ii), (g)(1)(iii), (g)(1)(vii), 
(g)(1)(viii), (g)(2)(i), (g)(2)(ii), (g)(2)(iii), (g)(2)(v), 
(g)(3)(ii), (g)(4)(i), and (g)(5).
    (ii) Industrial, commercial, and consumer activities. Requirements 
as specified in Sec.  721.80 (k) (manufacture, processing, or use of 
the PMN substance if the particle size is less than 10 microns) and 
(q).
    (iii) Release to water. Requirements as specified in Sec.  721.90 
(a)(4), (b)(4), and (c)(4) (N=1).
    (b) Specific requirements. The provisions of subpart A of this part 
apply to this section except as modified by this paragraph.
    (1) Recordkeeping. Recordkeeping requirements as specified in Sec.  
721.125 (a), (b), (c), (f), (g), (h), (i), and (k) are applicable to 
manufacturers, importers, and processors of this substance.
    (2) Limitations or revocation of certain notification requirements. 
The provisions of Sec.  721.185 apply to this section.
    (3) Determining whether a specific use is subject to this section. 
The provisions of Sec.  721.1725(b)(1) apply to this section.

0
14. By adding new Sec.  721.10014 to subpart E to read as follows:


Sec.  721.10014  Halogenated naphthalic anhydride (generic).

    (a) Chemical substance and significant new uses subject to 
reporting. (1) The chemical substance identified generically as 
halogenated naphthalic anhydride (PMN P-01-109) is subject to reporting 
under this section for the significant new uses described in paragraph 
(a)(2) of this section.
    (2) The significant new uses are:
    (i) Release to water. Requirements as specified in Sec.  721.90 
(a)(1), (b)(1), and (c)(1).
    (ii) [Reserved]
    (b) Specific requirements. The provisions of subpart A of this part 
apply to this section except as modified by this paragraph.
    (1) Recordkeeping. Recordkeeping requirements as specified in Sec.  
721.125 (a), (b), (c), and (k) are applicable to manufacturers, 
importers, and processors of this substance.
    (2) Limitations or revocation of certain notification requirements. 
The provisions of Sec.  721.185 apply to this section.

0
15. By adding new Sec.  721.10015 to subpart E to read as follows:


Sec.  721.10015  Halogenated benzimidazole (generic).

    (a) Chemical substance and significant new uses subject to 
reporting. (1) The chemical substance identified generically as 
halogenated benzimidazole (PMN P-01-110) is subject to reporting under 
this section for the significant new uses described in paragraph (a)(2) 
of this section.
    (2) The significant new uses are:
    (i) Release to water. Requirements as specified in Sec.  721.90 
(a)(1), (b)(1), and (c)(1).
    (ii) [Reserved]
    (b) Specific requirements. The provisions of subpart A of this part 
apply to this section except as modified by this paragraph.
    (1) Recordkeeping. Recordkeeping requirements as specified in Sec.  
721.125 (a), (b), (c), and (k) are applicable to manufacturers, 
importers, and processors of this substance.
    (2) Limitations or revocation of certain notification requirements. 
The provisions of Sec.  721.185 apply to this section.

0
16. By adding new Sec.  721.10016 to subpart E to read as follows:


Sec.  721.10016  Dibenzimidazothianaphthalene (generic).

    (a) Chemical substance and significant new uses subject to 
reporting. (1) The chemical substance identified generically as 
dibenzimidazothianaphthalene (PMN P-01-111) is subject to reporting 
under this section for the significant new uses described in paragraph 
(a)(2) of this section.
    (2) The significant new uses are:
    (i) Release to water. Requirements as specified in Sec.  721.90 
(a)(1), (b)(1), and (c)(1).
    (ii) [Reserved]
    (b) Specific requirements. The provisions of subpart A of this part 
apply to this section except as modified by this paragraph.
    (1) Recordkeeping. Recordkeeping requirements as specified in Sec.  
721.125 (a), (b), (c), and (k) are applicable to manufacturers, 
importers, and processors of this substance.
    (2) Limitations or revocation of certain notification requirements. 
The provisions of Sec.  721.185 apply to this section.

0
17. By adding new Sec.  721.10017 to subpart E to read as follows:


Sec.  721.10017  Amine terminated bisphenol A diglycidyl ether polymer 
(generic).

    (a) Chemical substances and significant new uses subject to 
reporting. (1) The chemical substances identified generically as amine 
terminated bisphenol A diglycidyl ether polymer (PMNs P-01-257/258/259 
and P-01-261) are subject to reporting under this section for the 
significant new uses described in paragraph (a)(2) of this section.
    (2) The significant new uses are:

[[Page 14701]]

    (i) Release to water. Requirements as specified in Sec.  721.90 
(a)(1), (b)(1), and (c)(1).
    (ii) [Reserved]
    (b) Specific requirements. The provisions of subpart A of this part 
apply to this section except as modified by this paragraph.
    (1) Recordkeeping. Recordkeeping requirements as specified in Sec.  
721.125 (a), (b), (c), and (k) are applicable to manufacturers, 
importers, and processors of this substance.
    (2) Limitations or revocation of certain notification requirements. 
The provisions of Sec.  721.185 apply to this section.

0
18. By adding new Sec.  721.10018 to subpart E to read as follows:


Sec.  721.10018  Calcium hydroxide oxide silicate 
(Ca<INF>6</INF>(OH)<INF>2</INF>O<INF>2</INF>(Si<INF>2</INF>O<INF>5</INF>
)<INF>3</INF>).

    (a) Chemical substance and significant new uses subject to 
reporting. (1) The chemical substance identified as calcium hydroxide 
oxide silicate 
(Ca<INF>6</INF>(OH)<INF>2</INF>O<INF>2</INF>(Si<INF>2</INF>O<INF>5</INF>
)<INF>3</INF>) (PMN P-01-442; CAS No. 13169-90-9) is subject to 
reporting under this section for the significant new uses described in 
paragraph (a)(2) of this section.
    (2) The significant new uses are:
    (i) Industrial, commercial, and consumer activities. Requirements 
as specified in Sec.  721.80 (f), (j) (use other than as filler to 
reinforce resins, additive for resins, and filter medium), (v)(1), and 
(x)(1).
    (ii) [Reserved]
    (b) Specific requirements. The provisions of subpart A of this part 
apply to this section except as modified by this paragraph.
    (1) Recordkeeping. Recordkeeping requirements as specified in Sec.  
721.125 (a), (b), (c), and (i) are applicable to manufacturers, 
importers, and processors of this substance.
    (2) Limitations or revocation of certain notification requirements. 
The provisions of Sec.  721.185 apply to this section.

0
19. By adding new Sec.  721.10019 to subpart E to read as follows:


Sec.  721.10019  Benzoic acid, 2-chloro-5-nitro-, 1,1-dimethyl-2-oxo-2-
(2-propenyloxy) ethyl ester.

    (a) Chemical substance and significant new uses subject to 
reporting. (1) The chemical substance identified as benzoic acid, 2-
chloro-5-nitro-, 1,1-dimethyl-2-oxo-2-(2-propenyloxy) ethyl ester (PMN 
P-01-563; CAS No. 174489-76-0) is subject to reporting under this 
section for the significant new uses described in paragraph (a)(2) of 
this section.
    (2) The significant new uses are:
    (i) Release to water. Requirements as specified Sec.  721.90 
(a)(1), (b)(1), and (c)(1).
    (ii) [Reserved]
    (b) Specific requirements. The provisions of subpart A of this part 
apply to this section except as modified by this paragraph.
    (1) Recordkeeping. Recordkeeping requirements as specified in Sec.  
721.125 (a), (b), (c), and (k) are applicable to manufacturers, 
importers, and processors of this substance.
    (2) Limitations or revocation of certain notification requirements. 
The provisions of Sec.  721.185 apply to this section.

0
20. By adding new Sec.  721.10020 to subpart E to read as follows:


Sec.  721.10020  Benzoic acid, 5-amino-2-chloro-, 1,1-dimethyl-2-oxo-2-
(2-propenyloxy) ethyl ester.

    (a) Chemical substance and significant new uses subject to 
reporting. (1) The chemical substance identified as benzoic acid, 5-
amino-2-chloro-, 1,1-dimethyl-2-oxo-2-(2-propenyloxy) ethyl ester (PMN 
P-01-564; CAS No. 174489-43-1) is subject to reporting under this 
section for the significant new uses described in paragraph (a)(2) of 
this section.
    (2) The significant new uses are:
    (i) Release to water. Requirements as specified Sec.  721.90 
(a)(1), (b)(1), and (c)(1).
    (ii) [Reserved]
    (b) Specific requirements. The provisions of subpart A of this part 
apply to this section except as modified by this paragraph.
    (1) Recordkeeping. Recordkeeping requirements as specified in Sec.  
721.125 (a), (b), (c), and (k) are applicable to manufacturers, 
importers, and processors of this substance.
    (2) Limitations or revocation of certain notification requirements. 
The provisions of Sec.  721.185 apply to this section.

0
21. By adding new Sec.  721.10021 to subpart E to read as follows:


Sec.  721.10021  Magnesium potassium titanium oxide.

    (a) Chemical substance and significant new uses subject to 
reporting. (1) The chemical substance identified as magnesium potassium 
titanium oxide (PMN P-01-764; CAS No. 39290-90-9) is subject to 
reporting under this section for the significant new uses described in 
paragraph (a)(2) of this section.
    (2) The significant new uses are:
    (i) Protection in the workplace. Requirements as specified in Sec.  
721.63 (a)(4), (a)(6)(i), (b) (concentration set at 0.1 percent), and 
(c). The following National Institute for Occupational Safety and 
Health (NIOSH)-approved respirators with an assigned protection factor 
(APF) of 10-25 meet the minimum requirements for Sec.  721.63(a)(4): 
Air-purifying, tight-fitting respirator equipped with N100 (if aerosols 
absent), R100, or P100 filters (either half- or full-face); powered 
air-purifying respirator equipped with a loose-fitting hood or helmet 
and High Efficiency Particulate Air (HEPA) filters; powered air-
purifying respirator equipped with a tight-fitting facepiece (either 
half- or full-face) and HEPA filters; and supplied-air respirator 
operated in pressure demand or continuous flow mode and equipped with a 
hood or helmet or tight-fitting facepiece (either half- or full-face). 
As an alternative to the respiratory requirements listed here, a 
manufacturer, importer, or processor may choose to follow the new 
chemical exposure limit (NCEL) provisions listed in the TSCA section 
5(e) consent order for this substance. The NCEL is 5 mg/m\3\ as an 8-
hour time-weighted average. Persons who wish to pursue NCELs as an 
alternative to the Sec.  721.63 respirator requirements may request to 
do so under 40 CFR 721.30. Persons whose Sec.  721.30 requests to use 
the NCELs approach are approved by EPA will receive NCELs provisions 
comparable to those contained in the corresponding section 5(e) consent 
order.
    (ii) Hazard communication program. Requirements as specified in 
Sec.  721.72 (a), (b), (c), (d), (e) (concentration set 0.1 percent), 
(f), (g)(1)(ii), (g)(2)(ii), (g)(2)(iv) (use respiratory protection or 
maintain workplace airborne concentrations at or below an 8-hour time-
weighted average of 5 mg/m\3\) and (g)(5).
    (iii) Industrial, commercial, and consumer activities. Requirements 
as specified in Sec.  721.80(q).
    (b) Specific requirements. The provisions of subpart A of this part 
apply to this section except as modified by this paragraph.
    (1) Recordkeeping. Recordkeeping requirements as specified in Sec.  
721.125 (a), (b), (c), (d), (f), (g), (h), and (i) are applicable to 
manufacturers, importers, and processors of this substance.
    (2) Limitations or revocation of certain notification requirements. 
The provisions of Sec.  721.185 apply to this section.
    (3) Determining whether a specific use is subject to this section. 
The provisions of Sec.  721.1725(b)(1) apply to this section.

0
22. By adding new Sec.  721.10022 to subpart E to read as follows:

[[Page 14702]]

Sec.  721.10022  Benzenamine, N-phenyl-, ar'-(C<INF>9</INF>-rich 
C<INF>8-10</INF>-branched alkyl) derivs.

    (a) Chemical substance and significant new uses subject to 
reporting. (1) The chemical substance identified as benzenamine, N-
phenyl-, ar'-(C<INF>9</INF>-rich C<INF>8-10</INF>-branched alkyl) 
derivs (PMN P-01-769; CAS No. 333955-69-4) is subject to reporting 
under this section for the significant new uses described in paragraph 
(a)(2) of this section.
    (2) The significant new uses are:
    (i) Industrial, commercial, and consumer activities. Requirements 
as specified in Sec.  721.80(j) (antioxidant for lubricating oils).
    (ii) Release to water. Requirements as specified in Sec.  721.90 
(a)(1), (b)(1), and (c)(1).
    (b) Specific requirements. The provisions of subpart A of this part 
apply to this section except as modified by this paragraph.
    (1) Recordkeeping. Recordkeeping requirements as specified in Sec.  
721.125 (a), (b), (c), (i), and (k) are applicable to manufacturers, 
importers, and processors of these substances.
    (2) Limitations or revocation of certain notification requirements. 
The provisions of Sec.  721.185 apply to this section.

0
23. By adding new Sec.  721.10023 to subpart E to read as follows:


Sec.  721.10023  Benzenamine, N-phenyl-, ar ar'-(C<INF>9</INF>-rich 
C<INF>8-10</INF>-branched alkyl) derivs.

    (a) Chemical substance and significant new uses subject to 
reporting. (1) The chemical substance identified as benzenamine, N-
phenyl-, ar,ar'-(C<INF>9</INF>-rich C<INF>8-10</INF>-branched alkyl) 
derivs (PMN P-01-770; CAS No. 333955-70-7) is subject to reporting 
under this section for the significant new uses described in paragraph 
(a)(2) of this section.
    (2) The significant new uses are:
    (i) Industrial, commercial, and consumer activities. Requirements 
as specified in Sec.  721.80(j) (antioxidant for lubricating oils).
    (ii) Release to water. Requirements as specified in Sec.  721.90 
(a)(1), (b)(1), and (c)(1).
    (b) Specific requirements. The provisions of subpart A of this part 
apply to this section except as modified by this paragraph.
    (1) Recordkeeping. Recordkeeping requirements as specified in Sec.  
721.125 (a), (b), (c), (i), and (k) are applicable to manufacturers, 
importers, and processors of these substances.
    (2) Limitations or revocation of certain notification requirements. 
The provisions of Sec.  721.185 apply to this section.

0
24. By adding new Sec.  721.10024 to subpart E to read as follows:


Sec.  721.10024  10H-Phenothiazine, ar-(C<INF>9</INF>-rich 
C<INF>8-10</INF>-branched alkyl) derivs.

    (a) Chemical substance and significant new uses subject to 
reporting. (1) The chemical substance identified as 10H-phenothiazine, 
ar-(C<INF>9</INF>-rich C<INF>8-10</INF>-branched alkyl) derivs (PMN P-
01-771; CAS No. 333955-79-6) is subject to reporting under this section 
for the significant new uses described in paragraph (a)(2) of this 
section.
    (2) The significant new uses are:
    (i) Industrial, commercial, and consumer activities. Requirements 
as specified in Sec.  721.80(j) (antioxidant for lubricating oils).
    (ii) Release to water. Requirements as specified in Sec.  721.90 
(a)(1), (b)(1), and (c)(1).
    (b) Specific requirements. The provisions of subpart A of this part 
apply to this section except as modified by this paragraph.
    (1) Recordkeeping. Recordkeeping requirements as specified in Sec.  
721.125 (a), (b), (c), (i), and (k) are applicable to manufacturers, 
importers, and processors of these substances.
    (2) Limitations or revocation of certain notification requirements. 
The provisions of Sec.  721.185 apply to this section.

0
25. By adding new Sec.  721.10025 to subpart E to read as follows:


Sec.  721.10025  10H-Phenothiazine, ar, ar'-(C<INF>9</INF>-rich 
C<INF>8-10</INF>-branched alkyl) derivs.

    (a) Chemical substance and significant new uses subject to 
reporting. (1) The chemical substances identified as 10H-phenothiazine, 
ar, ar'-(C<INF>9</INF>-rich C<INF>8-10</INF>-branched alkyl) derivs 
(PMN P-01-772; CAS No. 333955-80-9) is subject to reporting under this 
section for the significant new uses described in paragraph (a)(2) of 
this section.
    (2) The significant new uses are:
    (i) Industrial, commercial, and consumer activities. Requirements 
as specified in Sec.  721.80(j) (antioxidant for lubricating oils).
    (ii) Release to water. Requirements as specified in Sec.  721.90 
(a)(1), (b)(1), and (c)(1).
    (b) Specific requirements. The provisions of subpart A of this part 
apply to this section except as modified by this paragraph.
    (1) Recordkeeping. Recordkeeping requirements as specified in Sec.  
721.125 (a), (b), (c), (i), and (k) are applicable to manufacturers, 
importers, and processors of these substances.
    (2) Limitations or revocation of certain notification requirements. 
The provisions of Sec.  721.185 apply to this section.

0
26. By adding new Sec.  721.10026 to subpart E to read as follows:


Sec.  721.10026  Cashew, nutshell liq., ethoxylated.

    (a) Chemical substance and significant new uses subject to 
reporting. (1) The chemical substance identified as cashew, nutshell 
liq., ethoxylated (PMN P-01-856; CAS No. 350820-95-0) is subject to 
reporting under this section for the significant new uses described in 
paragraph (a)(2) of this section.
    (2) The significant new uses are:
    (i) Industrial, commercial, and consumer activities. Requirements 
as specified in Sec.  721.80(k) (any manufacturing, processing, or use 
of the PMN substance with less than 55 moles of the ethoxy or with an 
average molecular weight less than 2,700 daltons).
    (ii) [Reserved]
    (b) Specific requirements. The provisions of subpart A of this part 
apply to this section except as modified by this paragraph.
    (1) Recordkeeping. Recordkeeping requirements as specified in Sec.  
721.125 (a), (b), (c), and (i) are applicable to manufacturers, 
importers, and processors of this substance.
    (2) Limitations or revocation of certain notification requirements. 
The provisions of Sec.  721.185 apply to this section.

0
27. By adding new Sec.  721.10027 to subpart E to read as follows:


Sec.  721.10027  Ethoxylated alkylsulfate, substituted alkylamine salt 
(generic).

    (a) Chemical substance and significant new uses subject to 
reporting. (1) The chemical substance identified generically as 
ethoxylated alkylsulfate, substituted alkylamine salt (PMN P-01-862) is 
subject to reporting under this section for the significant new uses 
described in paragraph (a)(2) of this section.
    (2) The significant new uses are:
    (i) Industrial, commercial, and consumer activities. Requirements 
as specified in Sec.  721.80(j).
    (ii) [Reserved]
    (b) Specific requirements. The provisions of subpart A of this part 
apply to this section except as modified by this paragraph.
    (1) Recordkeeping. Recordkeeping requirements as specified in Sec.  
721.125 (a), (b), (c), and (i) are applicable to manufacturers, 
importers, and processors of this substance.
    (2) Limitations or revocation of certain notification requirements. 
The provisions of Sec.  721.185 apply to this section.
    (3) Determining whether a specific use is subject to this section. 
The provisions of Sec.  721.1725(b)(1) apply to this section.

[[Page 14703]]


0
28. By adding new Sec.  721.10028 to subpart E to read as follows:


Sec.  721.10028  Disubstituted benzene metal salts (generic).

    (a) Chemical substances and significant new uses subject to 
reporting. (1) The chemical substances identified generically as 
disubstituted benzene metal salts (PMNs P-01-901 and P-01-902) are 
subject to reporting under this section for the significant new uses 
described in paragraph (a)(2) of this section.
    (2) The significant new uses are:
    (i) Protection in the workplace. Requirements as specified in Sec.  
721.63 (a)(1) and (a)(3).
    (ii) Industrial, commercial, and consumer activities. Requirements 
as specified in Sec.  721.80(j).
    (b) Specific requirements. The provisions of subpart A of this part 
apply to this section except as modified by this paragraph.
    (1) Recordkeeping. Recordkeeping requirements as specified in Sec.  
721.125 (a), (b), (c), (d), (e), and (i) are applicable to 
manufacturers, importers, and processors of this substance.
    (2) Limitations or revocation of certain notification requirements. 
The provisions of Sec.  721.185 apply to this section.
    (3) Determining whether a specific use is subject to this section. 
The provisions of Sec.  721.1725(b)(1) apply to this section.

0
29. By adding new Sec.  721.10029 to subpart E to read as follows:


Sec.  721.10029  Isocyanate compound, modified with methoxysilane 
(generic).

    (a) Chemical substance and significant new uses subject to 
reporting. (1) The chemical substance identified generically as 
isocyanate compound, modified with methoxysilane (PMN P-01-918) is 
subject to reporting under this section for the significant new uses 
described in paragraph (a)(2) of this section.
    (2) The significant new uses are:
    (i) Protection in the workplace. Requirements as specified in Sec.  
721.63 (a)(1), (a)(2)(i), (a)(2)(ii), (a)(2)(iii), (a)(2)(iv), (a)(3), 
(a)(4), and (a)(6). The following National Institute for Occupational 
Safety and Health (NIOSH)-approved respirators meet the minimum 
requirement for Sec.  721.63(a)(4): Air-purifying, tight-fitting full-
face respirator equipped with N100 (if oil aerosols absent), R100, or 
P100 filters; powered air-purifying respirator equipped with a tight-
fitting full facepiece and High Efficiency Particulate Air (HEPA) 
filters; supplied-air respirator operated in pressure demand or 
continuous flow mode and equipped with a tight-fitting full facepiece. 
As an alternative to the respiratory requirements listed here, a 
manufacturer, importer, or processor may choose to follow the new 
chemical exposure limit (NCEL) provisions listed in the TSCA section 
5(e) consent order for this substance. The NCEL is 0.05 mg/m\3\ as an 
8-hour time-weighted average. Persons who wish to pursue NCELs as an 
alternative to the Sec.  721.63 respirator requirements may request to 
do so under 40 CFR 721.30. Persons whose Sec.  721.30 requests to use 
the NCELs approach are approved by EPA will receive NCELs provisions 
comparable to those contained in the corresponding section 5(e) consent 
order.
    (ii) Hazard communication program. Requirements as specified in 
Sec.  721.72 (a), (b), (c), (d), (e) (concentration set 1.0 percent), 
(f), (g)(1)(i), (g)(1)(ii), (g)(2)(i), (g)(2)(ii), (g)(2)(iv) (use 
respiratory protection or maintain workplace airborne concentrations at 
or below an 8-hour time-weighted average of 0.05 mg/m\3\), (g)(2)(v), 
and (g)(5). The following statements shall appear on each label as 
specified in Sec.  721.72(b) and the Material Safety Data Sheet (MSDS) 
as specified in Sec.  721.72(c): This substance may cause skin 
irritation and sensitization.
    (iii) Industrial, commercial, and consumer activities. Requirements 
as specified in Sec.  721.80(q).
    (b) Specific requirements. The provisions of subpart A of this part 
apply to this section except as modified by this paragraph.
    (1) Recordkeeping. Recordkeeping requirements as specified in Sec.  
721.125 (a), (b), (c), (d), (e), (f), (g), (h), and (i) are applicable 
to manufacturers, importers, and processors of this substance.
    (2) Limitations or revocation of certain notification requirements. 
The provisions of Sec.  721.185 apply to this section.
    (3) Determining whether a specific use is subject to this section. 
The provisions of Sec.  721.1725(b)(1) apply to this section.

0
30. By adding new Sec.  721.10030 to subpart E to read as follows:


Sec.  721.10030  Pyrimido[5,4-g]pteridine-2,4,6,8-tetramine, 4-
methylbenzenesulfonate, base-hydrolyzed.

    (a) Chemical substance and significant new uses subject to 
reporting. (1) The chemical substance identified as pyrimido[5,4-
g]pteridine-2,4,6,8-tetramine, 4-methylbenzenesulfonate, base-
hydrolyzed (PMN P-01-919; CAS No. 346709-25-9) is subject to reporting 
under this section for the significant new uses described in paragraph 
(a)(2) of this section.
    (2) The significant new uses are:
    (i) Industrial, commercial, and consumer activities. Requirements 
as specified in Sec.  721.80(f).
    (ii) [Reserved]
    (b) Specific requirements. The provisions of subpart A of this part 
apply to this section except as modified by this paragraph.
    (1) Recordkeeping. Recordkeeping requirements as specified in Sec.  
721.125 (a), (b), (c), and (i) are applicable to manufacturers, 
importers, and processors of this substance.
    (2) Limitations or revocation of certain notification requirements. 
The provisions of Sec.  721.185 apply to this section.

0
31. By adding new Sec.  721.10031 to subpart E to read as follows:


Sec.  721.10031  Lithium potassium titanium oxide.

    (a) Chemical substance and significant new uses subject to 
reporting. (1) The chemical substance identified as lithium potassium 
titanium oxide (PMN P-02-214; CAS No. 39318-30-4) is subject to 
reporting under this section for the significant new uses described in 
paragraph (a)(2) of this section.
    (2) The significant new uses are:
    (i) Protection in the workplace. Requirements as specified in Sec.  
721.63 (a)(4), (a)(6)(i), (b) (concentration set at 0.1 percent), and 
(c). The following National Institute for Occupational Safety and 
Health (NIOSH)-approved respirators with an APF of 10-25 meet the 
minimum requirements for Sec.  721.63(a)(4): Air-purifying, tight-
fitting respirator (either half- or full-face) equipped with N100 (if 
aerosols absent), R100, or P100 filters; powered air-purifying, 
respirator equipped with a loose-fitting hood or helmet or tight-
fitting facepiece (either half- or full-face) and High Efficiency 
Particulate Air (HEPA) filters; and supplied-air respirator operated in 
pressure demand or continuous flow mode and equipped with a hood or 
helmet or tight-fitting facepiece (either half- or full-face). As an 
alternative to the respiratory requirements listed here, a 
manufacturer, importer, or processor may choose to follow the new 
chemical exposure limit (NCEL) provisions listed in the TSCA section 
5(e) consent order for this substance. The NCEL is 5 mg/m\3\ as an 8-
hour time-weighted average. Persons who wish to pursue NCELs as an 
alternative to the Sec.  721.63 respirator requirements may request to 
do so under 40 CFR 721.30. Persons whose Sec.  721.30 requests to use 
the NCELs approach are approved by EPA will receive NCELs provisions 
comparable to

[[Page 14704]]

those contained in the corresponding section 5(e) consent order.
    (ii) Hazard communication program. Requirements as specified in 
Sec.  721.72 (a), (b), (c), (d), (e) (concentration set 0.1 percent), 
(f), (g)(1)(ii), (g)(2)(ii), (g)(2)(iv) (use respiratory protection or 
maintain workplace airborne concentrations at or below an 8-hour time-
weighted average of 5 mg/m\3\), and (g)(5).
    (iii) Industrial, commercial, and consumer activities. Requirements 
as specified in Sec.  721.80(q).
    (b) Specific requirements. The provisions of subpart A of this part 
apply to this section except as modified by this paragraph.
    (1) Recordkeeping. Recordkeeping requirements as specified in Sec.  
721.125 (a), (b), (c), (d), (f), (g), (h), and (i) are applicable to 
manufacturers, importers, and processors of this substance.
    (2) Limitations or revocation of certain notification requirements. 
The provisions of Sec.  721.185 apply to this section.
    (3) Determining whether a specific use is subject to this section. 
The provisions of Sec.  721.1725(b)(1) apply to this section.

0
32. By adding new Sec.  721.10032 to subpart E to read as follows:


Sec.  721.10032  Acrylic acid, polymer with substituted acrylamides 
(generic).

    (a) Chemical substance and significant new uses subject to 
reporting. (1) The chemical substance identified generically as acrylic 
acid, polymer with substituted acrylamides (PMN P-02-269) is subject to 
reporting under this section for the significant new uses described in 
paragraph (a)(2) of this section.
    (2) The significant new uses are:
    (i) Industrial, commercial, and consumer activities. Requirements 
as specified in Sec.  721.80(k) (any manufacturing, processing, or use 
of the PMN substance with an aerodynamic diameter less than 10 
microns).
    (ii) [Reserved]
    (b) Specific requirements. The provisions of subpart A of this part 
apply to this section except as modified by this paragraph.
    (1) Recordkeeping. Recordkeeping requirements as specified in Sec.  
721.125 (a), (b), (c), and (i) are applicable to manufacturers, 
importers, and processors of this substance.
    (2) Limitations or revocation of certain notification requirements. 
The provisions of Sec.  721.185 apply to this section.

0
33. By adding new Sec.  721.10033 to subpart E to read as follows:


Sec.  721.10033  Zinc, [ethanedioato(2-)-. kappa. O\1\, . kappa. 
O\2\]-.

    (a) Chemical substance and significant new uses subject to 
reporting. (1) The chemical substance identified as zinc, 
[ethanedioato(2-)-. kappa. O\1\, . kappa. O\2\]- (PMN P-02-322; CAS No. 
547-68-2) is subject to reporting under this section for the 
significant new uses described in paragraph (a)(2) of this section.
    (2) The significant new uses are:
    (i) Release to water. Requirements as specified Sec.  721.90 
(a)(4), (b)(4), and (c)(4) (N=1).
    (ii) [Reserved]
    (b) Specific requirements. The provisions of subpart A of this part 
apply to this section except as modified by this paragraph.
    (1) Recordkeeping. Recordkeeping requirements as specified in Sec.  
721.125 (a), (b), (c), and (k) are applicable to manufacturers, 
importers, and processors of this substance.
    (2) Limitations or revocation of certain notification requirements. 
The provisions of Sec.  721.185 apply to this section.

0
34. By adding new Sec.  721.10034 to subpart E to read as follows:


Sec.  721.10034  Substituted pyridine coupled with diazotized 
substituted nitrobenzonitrile, diazotized substituted benzenamine and 
substituted pyridinecarbonitrile (generic).

    (a) Chemical substance and significant new uses subject to 
reporting. (1) The chemical substance identified generically as 
substituted pyridine coupled with diazotized substituted 
nitrobenzonitrile, diazotized substituted benzenamine and substituted 
pyridinecarbonitrile (PMN P-02-359) is subject to reporting under this 
section for the significant new uses described in paragraph (a)(2) of 
this section.
    (2) The significant new uses are:
    (i) Release to water. Requirements as specified Sec.  721.90 
(a)(4), (b)(4), and (c)(4) (N=1).
    (ii) [Reserved]
    (b) Specific requirements. The provisions of subpart A of this part 
apply to this section except as modified by this paragraph.
    (1) Recordkeeping. Recordkeeping requirements as specified in Sec.  
721.125 (a), (b), (c), and (k) are applicable to manufacturers, 
importers, and processors of this substance.
    (2) Limitations or revocation of certain notification requirements. 
The provisions of Sec.  721.185 apply to this section.

0
35. By adding new Sec.  721.10035 to subpart E to read as follows:


Sec.  721.10035  Alkylbenzene sulfonate (generic).

    (a) Chemical substance and significant new uses subject to 
reporting. (1) The chemical substance identified generically as 
alkylbenzene sulfonate (PMN-02-382) is subject to reporting under this 
section for the significant new uses described in paragraph (a)(2) of 
this section.
    (2) The significant new uses are:
    (i) Industrial, commercial, and consumer activities. Requirements 
as specified in Sec.  721.80(k) (manufacture, import, or processing of 
the chemical without 19 percent or more mineral oil as a diluent).
    (ii) [Reserved]
    (b) Specific requirements. The provisions of subpart A of this part 
apply to this section except as modified by this paragraph.
    (1) Recordkeeping. Recordkeeping requirements as specified in Sec.  
721.125 (a), (b), (c), and (i) are applicable to manufacturers, 
importers, and processors of this substance.
    (2) Limitations or revocation of certain notification requirements. 
The provisions of Sec.  721.185 apply to this section.

0
36. By adding new Sec.  721.10036 to subpart E to read as follows:


Sec.  721.10036  Acetaldehyde based polymer (generic).

    (a) Chemical substance and significant new uses subject to 
reporting. (1) The chemical substance identified generically as 
acetaldehyde based polymer (PMN P-02-406) is subject to reporting under 
this section for the significant new uses described in paragraph (a)(2) 
of this section.
    (2) The significant new uses are:
    (i) Industrial, commercial, and consumer activities. Requirements 
as specified in Sec.  721.80(f).
    (ii) Release to water. Requirements as specified Sec.  721.90 
(b)(1) and (c)(1).
    (b) Specific requirements. The provisions of subpart A of this part 
apply to this section except as modified by this paragraph.
    (1) Recordkeeping. Recordkeeping requirements as specified in Sec.  
721.125 (a), (b), (c), (i), and (k) are applicable to manufacturers, 
importers, and processors of this substance.
    (2) Limitations or revocation of certain notification requirements. 
The provisions of Sec.  721.185 apply to this section.

0
37. By adding new Sec.  721.10037 to subpart E to read as follows:

[[Page 14705]]

Sec.  721.10037  Complex halogenated salt of 
tris(ethylatedaminocarbocyclic)methane (generic).

    (a) Chemical substance and significant new uses subject to 
reporting. (1) The chemical substance identified generically as complex 
halogenated salt of tris(ethylatedaminocarbocyclic)methane (PMN P-02-
423) is subject to reporting under this section for the significant new 
uses described in paragraph (a)(2) of this section.
    (2) The significant new uses are:
    (i) Industrial, commercial, and consumer activities. Requirements 
as specified in Sec.  721.80 (d) and (e).
    (ii) Release to water. Requirements as specified in Sec.  721.90 
(a)(4), (b)(4), and (c)(4) (N=1).
    (b) Specific requirements. The provisions of subpart A of this part 
apply to this section except as modified by this paragraph.
    (1) Recordkeeping. Recordkeeping requirements as specified in Sec.  
721.125 (a), (b), (c), (i), and (k) are applicable to manufacturers, 
importers, and processors of this substance.
    (2) Limitations or revocation of certain notification requirements. 
The provisions of Sec.  721.185 apply to this section.

0
38. By adding new Sec.  721.10038 to subpart E to read as follows:


Sec.  721.10038  Trimellitic anhydride, polymer with substituted 
glycol, alkyl phenols and ethoxylated nonylphenol (generic).

    (a) Chemical substance and significant new uses subject to 
reporting. (1) The chemical substance identified generically as 
trimellitic anhydride, polymer with substituted glycol, alkyl phenols 
and ethoxylated nonylphenol (PMN P-02-434) is subject to reporting 
under this section for the significant new uses described in paragraph 
(a)(2) of this section.
    (2) The significant new uses are:
    (i) Release to water. Requirements as specified Sec.  721.90 
(a)(1), (b)(1), and (c)(1).
    (ii) [Reserved]
    (b) Specific requirements. The provisions of subpart A of this part 
apply to this section except as modified by this paragraph.
    (1) Recordkeeping. Recordkeeping requirements as specified in Sec.  
721.125 (a), (b), (c), and (k) are applicable to manufacturers, 
importers, and processors of this substance.
    (2) Limitations or revocation of certain notification requirements. 
The provisions of Sec.  721.185 apply to this section.

0
39. By adding new Sec.  721.10039 to subpart E to read as follows:


Sec.  721.10039  Diethoxybenzenamine derivative, diazotized, coupled 
with aminonaphthalenesulfonic acid derivative, ammonium salt (generic).

    (a) Chemical substance and significant new uses subject to 
reporting. (1) The chemical substance identified generically as a 
diethoxybenzenamine derivative, diazotized, coupled with 
aminonaphthalenesulfonic acid derivative, ammonium salt (PMN P-02-514) 
is subject to reporting under this section for the significant new uses 
described in paragraph (a)(2) of this section.
    (2) The significant new uses are:
    (i) Industrial, commercial, and consumer activities. Requirements 
as specified in Sec.  721.80 (f), (v)(2), and (x)(2).
    (ii) [Reserved]
    (b) Specific requirements. The provisions of subpart A of this part 
apply to this section except as modified by this paragraph.
    (1) Recordkeeping. Recordkeeping requirements as specified in Sec.  
721.125 (a), (b), (c), and (i) are applicable to manufacturers, 
importers, and processors of this substance.
    (2) Limitations or revocation of certain notification requirements. 
The provisions of Sec.  721.185 apply to this section.

0
40. By adding new Sec.  721.10040 to subpart E to read as follows:


Sec.  721.10040  Substituted acridine naphtha substituted benzamide 
(generic).

    (a) Chemical substance and significant new uses subject to 
reporting. (1) The chemical substance identified generically as a 
substituted acridine naphtha substituted benzamide (PMN P-02-522) is 
subject to reporting under this section for the significant new uses 
described in paragraph (a)(2) of this section.
    (2) The significant new uses are:
    (i) Release to water. Requirements as specified Sec.  721.90 
(a)(4), (b)(4), and (c)(4) (N=2).
    (ii) [Reserved]
    (b) Specific requirements. The provisions of subpart A of this part 
apply tothis section except as modified by this paragraph.
    (1) Recordkeeping. Recordkeeping requirements as specified in Sec.  
721.125 (a), (b), (c), and (k) are applicable to manufacturers, 
importers, and processors of this substance.
    (2) Limitations or revocation of certain notification requirements. 
The provisions of Sec.  721.185 apply to this section.

0
41. By adding new Sec.  721.10041 to subpart E to read as follows:


Sec.  721.10041  1-Butanone, 2-(dimethylamino)-2-[(4-
methylphenyl)methyl]-1-[4-(4-morpholinyl)phenyl]-.

    (a) Chemical substance and significant new uses subject to 
reporting. (1) The chemical substance identified as 1-butanone, 2-
(dimethylamino)-2-[(4-methylphenyl)methyl]-1-[4-(4-morpholinyl)phenyl]-
(PMN P-02-530; CAS No. 119344-86-4) is subject to reporting under this 
section for the significant new uses described in paragraph (a)(2) of 
this section.
    (2) The significant new uses are:
    (i) Industrial, commercial, and consumer activities. Requirements 
as specified in Sec.  721.80(f).
    (ii) [Reserved]
    (b) Specific requirements. The provisions of subpart A of this part 
apply to this section except as modified by this paragraph.
    (1) Recordkeeping. Recordkeeping requirements as specified in Sec.  
721.125 (a), (b), (c), and (i) are applicable to manufacturers, 
importers, and processors of this substance.
    (2) Limitations or revocation of certain notification requirements. 
The provisions of Sec.  721.185 apply to this section.

0
42. By adding new Sec.  721.10042 to subpart E to read as follows:


Sec.  721.10042  2-Propanol, 1-[bis(2-hydroxyethyl)amino]-.

    (a) Chemical substance and significant new uses subject to 
reporting. (1) The chemical substance identified as 2-propanol, 1-
[bis(2-hydroxyethyl)amino]- (PMN P-02-585; CAS No. 6712-98-7) is 
subject to reporting under this section for the significant new uses 
described in paragraph (a)(2) of this section.
    (2) The significant new uses are:
    (i) Industrial, commercial, and consumer activities. Requirements 
as specified in Sec.  721.80(j).
    (ii) [Reserved]
    (b) Specific requirements. The provisions of subpart A of this part 
apply to this section except as modified by this paragraph.
    (1) Recordkeeping. Recordkeeping requirements as specified in Sec.  
721.125 (a), (b), (c), and (i) are applicable to manufacturers, 
importers, and processors of this substance.
    (2) Limitations or revocation of certain notification requirements. 
The provisions of Sec.  721.185 apply to this section.
    (3) Determining whether a specific use is subject to this section. 
The provisions of Sec.  721.1725(b)(1) apply to this section.

0
43. By adding new Sec.  721.10043 to subpart E to read as follows:

[[Page 14706]]

Sec.  721.10043  Dineopentyl-4-substituted phthalate (generic).

    (a) Chemical substance and significant new uses subject to 
reporting. (1) The chemical substance identified generically as 
dineopentyl-4-substituted phthalate (PMN P-02-697) is subject to 
reporting under this section for the significant new uses described in 
paragraph (a)(2) of this section.
    (2) The significant new uses are:
    (i) Industrial, commercial, and consumer activities. Requirements 
as specified in Sec.  721.80(j).
    (ii) Release to water. Requirements as specified Sec.  721.90 
(a)(1), (b)(1), and (c)(1).
    (b) Specific requirements. The provisions of subpart A of this part 
apply tothis section except as modified by this paragraph.
    (1) Recordkeeping. Recordkeeping requirements as specified in Sec.  
721.125 (a), (b), (c), (i), and (k) are applicable to manufacturers, 
importers, and processors of this substance.
    (2) Limitations or revocation of certain notification requirements. 
The provisions of Sec.  721.185 apply to this section.
    (3) Determining whether a specific use is subject to this section. 
The provisions of Sec.  721.1725(b)(1) apply to this section.

0
44. By adding new Sec.  721.10044 to subpart E to read as follows:


Sec.  721.10044  Metal oxide, modified with alkyl and vinyl terminated 
polysiloxanes (generic).

    (a) Chemical substance and significant new uses subject to 
reporting. (1) The chemical substance identified generically as metal 
oxide, modified with alkyl and vinyl terminated polysiloxanes (PMN P-
02-698) is subject to reporting under this section for the significant 
new uses described in paragraph (a)(2) of this section.
    (2) The significant new uses are:
    (i) Industrial, commercial, and consumer activities. Requirements 
as specified in Sec.  721.80 (v)(1), (w)(1), and (x)(1).
    (ii) [Reserved]
    (b) Specific requirements. The provisions of subpart A of this part 
apply to this section except as modified by this paragraph.
    (1) Recordkeeping. Recordkeeping requirements as specified in Sec.  
721.125 (a), (b), (c), and (i) are applicable to manufacturers, 
importers, and processors of this substance.
    (2) Limitations or revocation of certain notification requirements. 
The provisions of Sec.  721.185 apply to this section.

0
45. By adding new Sec.  721.10045 to subpart E to read as follows:


Sec.  721.10045  Diazotized substituted heteromonocycle coupled with 
naphthalene sulfonic acid derivative, nickel complex, alkaline salt 
(generic).

    (a) Chemical substance and significant new uses subject to 
reporting. (1) The chemical substance identified generically as a 
diazotized substituted heteromonocycle coupled with naphthalene 
sulfonic acid derivative, nickel complex, alkaline salt (PMN P-02-737) 
is subject to reporting under this section for the significant new uses 
described in paragraph (a)(2) of this section.
    (2) The significant new uses are:
    (i) Industrial, commercial, and consumer activities. Requirements 
as specified in Sec.  721.80 (f), (v)(2), and (x)(2).
    (ii) [Reserved]
    (b) Specific requirements. The provisions of subpart A of this part 
apply to this section except as modified by this paragraph.
    (1) Recordkeeping. Recordkeeping requirements as specified in Sec.  
721.125 (a), (b), (c), and (i) are applicable to manufacturers, 
importers, and processors of this substance.
    (2) Limitations or revocation of certain notification requirements. 
The provisions of Sec.  721.185 apply to this section.

0
46. By adding new Sec.  721.10046 to subpart E to read as follows:


Sec.  721.10046  Polyaromatic amine phosphate (generic).

    (a) Chemical substance and significant new uses subject to 
reporting. (1) The chemical substance identified generically as 
polyaromatic amine phosphate (PMN P-02-747) is subject to reporting 
under this section for the significant new uses described in paragraph 
(a)(2) of this section.
    (2) The significant new uses are:
    (i) Release to water. Requirements as specified Sec.  721.90 
(a)(1), (b)(1), and (c)(1).
    (ii) [Reserved]
    (b) Specific requirements. The provisions of subpart A of this part 
apply to this section except as modified by this paragraph.
    (1) Recordkeeping. Recordkeeping requirements as specified in Sec.  
721.125 (a), (b), (c), and (k) are applicable to manufacturers, 
importers, and processors of this substance.
    (2) Limitations or revocation of certain notification requirements. 
The provisions of Sec.  721.185 apply to this section.

0
47. By adding new Sec.  721.10047 to subpart E to read as follows:


Sec.  721.10047  Polyphosphoric acids, compds. with piperazine.

    (a) Chemical substance and significant new uses subject to 
reporting. (1) The chemical substance identified as a polyphosphoric 
acids, compds. with piperazine (PMN P-02-766; CAS No. 383905-85-9) is 
subject to reporting under this section for the significant new uses 
described in paragraph (a)(2) of this section.
    (2) The significant new uses are:
    (i) Industrial, commercial, and consumer activities. Requirements 
as specified in Sec.  721.80(j).
    (ii) [Reserved]
    (b) Specific requirements. The provisions of subpart A of this part 
apply to this section except as modified by this paragraph.
    (1) Recordkeeping. Recordkeeping requirements as specified in Sec.  
721.125 (a), (b), (c), and (i) are applicable to manufacturers, 
importers, and processors of this substance.
    (2) Limitations or revocation of certain notification requirements. 
The provisions of Sec.  721.185 apply to this section.
    (3) Determining whether a specific use is subject to this section. 
The provisions of Sec.  721.1725(b)(1) apply to this section.

0
48. By adding new Sec.  721.10048 to subpart E to read as follows:


Sec.  721.10048  Substituted anthraquinone (generic).

    (a) Chemical substance and significant new uses subject to 
reporting. (1) The chemical substance identified generically as 
substituted anthraquinone (PMN P-02-869) is subject to reporting under 
this section for the significant new uses described in paragraph (a)(2) 
of this section.
    (2) The significant new uses are:
    (i) Industrial, commercial, and consumer activities. Requirements 
as specified in Sec.  721.80(s) (4,500 kilograms).
    (ii) [Reserved]
    (b) Specific requirements. The provisions of subpart A of this part 
apply to this section except as modified by this paragraph.
    (1) Recordkeeping. Recordkeeping requirements as specified in Sec.  
721.125 (a), (b), (c), and (i) are applicable to manufacturers, 
importers, and processors of this substance.
    (2) Limitations or revocation of certain notification requirements. 
The provisions of Sec.  721.185 apply to this section.

0
49. By adding new Sec.  721.10049 to subpart E to read as follows:

[[Page 14707]]

Sec.  721.10049  Phenol, 4,4'- cyclohexylidene bis[2-methyl-.

    (a) Chemical substance and significant new uses subject to 
reporting. (1) The chemical substance identified as a phenol, 4,4'- 
cyclohexylidene bis[2-methyl- (PMN P-02-912; CAS No. 2362-14-3) is 
subject to reporting under this section for the significant new uses 
described in paragraph (a)(2) of this section.
    (2) The significant new uses are:
    (i) Release to water. Requirements as specified Sec.  721.90 
(a)(1), (b)(1), and (c)(1).
    (ii) [Reserved]
    (b) Specific requirements. The provisions of subpart A of this part 
apply to this section except as modified by this paragraph.
    (1) Recordkeeping. Recordkeeping requirements as specified in Sec.  
721.125 (a), (b), (c), and (k) are applicable to manufacturers, 
importers, and processors of this substance.
    (2) Limitations or revocation of certain notification requirements. 
The provisions of Sec.  721.185 apply to this section.

0
50. By adding new Sec.  721.10050 to subpart E to read as follows:


Sec.  721.10050  Disubstituted-N'- hydroxy-benzenecarboximidamide 
(generic).

    (a) Chemical substance and significant new uses subject to 
reporting. (1) The chemical substance identified generically as 
disubstituted-N'- hydroxy-benzenecarboximidamide (PMN P-02-929) is 
subject to reporting under this section for the significant new uses 
described in paragraph (a)(2) of this section.
    (2) The significant new uses are:
    (i) Industrial, commercial, and consumer activities. Requirements 
as specified in Sec.  721.80(g).
    (ii) [Reserved]
    (b) Specific requirements. The provisions of subpart A of this part 
apply to this section except as modified by this paragraph.
    (1) Recordkeeping. Recordkeeping requirements as specified in Sec.  
721.125 (a), (b), (c), and (i) are applicable to manufacturers, 
importers, and processors of this substance.
    (2) Limitations or revocation of certain notification requirements. 
The provisions of Sec.  721.185 apply to this section.

0
51. By adding new Sec.  721.10051 to subpart E to read as follows:


Sec.  721.10051  Spiro naphthoxazine (generic).

    (a) Chemical substance and significant new uses subject to 
reporting. (1) The chemical substance identified generically as spiro 
naphthoxazine (PMN P-02-961) is subject to reporting under this section 
for the significant new uses described in paragraph (a)(2) of this 
section.
    (2) The significant new uses are:
    (i) Industrial, commercial, and consumer activities. Requirements 
as specified in Sec.  721.80(f).
    (ii) [Reserved]
    (b) Specific requirements. The provisions of subpart A of this part 
apply to this section except as modified by this paragraph.
    (1) Recordkeeping. Recordkeeping requirements as specified in Sec.  
721.125 (a), (b), (c), and (i) are applicable to manufacturers, 
importers, and processors of this substance.
    (2) Limitations or revocation of certain notification requirements. 
The provisions of Sec.  721.185 apply to this section.

0
52. By adding new Sec.  721.10052 to subpart E to read as follows:


Sec.  721.10052  Aminoalkyl substituted alkylphenol (generic).

    (a) Chemical substance and significant new uses subject to 
reporting. (1) The chemical substance identified generically as 
aminoalkyl substituted alkylphenol (PMN P-02-1088) is subject to 
reporting under this section for the significant new uses described in 
paragraph (a)(2) of this section.
    (2) The significant new uses are:
    (i) Industrial, commercial, and consumer activities. Requirements 
as specified in Sec.  721.80(j).
    (ii) [Reserved]
    (b) Specific requirements. The provisions of subpart A of this part 
apply to this section except as modified by this paragraph.
    (1) Recordkeeping. Recordkeeping requirements as specified in Sec.  
721.125 (a), (b), (c), and (i) are applicable to manufacturers, 
importers, and processors of this substance.
    (2) Limitations or revocation of certain notification requirements. 
The provisions of Sec.  721.185 apply to this section.
    (3) Determining whether a specific use is subject to this section. 
The provisions of Sec.  721.1725(b)(1) apply to this section.

0
53. By adding new Sec.  721.10053 to subpart E to read as follows:


Sec.  721.10053  Alkyl silane methacrylate (generic).

    (a) Chemical substance and significant new uses subject to 
reporting. (1) The chemical substance identified generically as alkyl 
silane methacrylate (PMN P-03-41) is subject to reporting under this 
section for the significant new uses described in paragraph (a)(2) of 
this section.
    (2) The significant new uses are:
    (i) Release to water. Requirements as specified Sec.  721.90 
(a)(1), (b)(1), and (c)(1).
    (ii) [Reserved]
    (b) Specific requirements. The provisions of subpart A of this part 
apply to this section except as modified by this paragraph.
    (1) Recordkeeping. Recordkeeping requirements as specified in Sec.  
721.125 (a), (b), (c), and (k) are applicable to manufacturers, 
importers, and processors of this substance.
    (2) Limitations or revocation of certain notification requirements. 
The provisions of Sec.  721.185 apply to this section.

0
54. By adding new Sec.  721.10054 to subpart E to read as follows:


Sec.  721.10054  Phenol, polymer with formaldehyde, 3-[(2-
aminocyclohexyl)amino]-2-hydroxypropyl ethers.

    (a) Chemical substance and significant new uses subject to 
reporting. (1) The chemical substance identified generically as a 
phenol, polymer with formaldehyde, 3-[(2-aminocyclohexyl)amino]-2-
hydroxypropyl ethers (PMN P-03-43; CAS No. 452082-53-0) is subject to 
reporting under this section for the significant new uses described in 
paragraph (a)(2) of this section.
    (2) The significant new uses are:
    (i) Release to water. Requirements as specified Sec.  721.90 
(a)(1), (b)(1), and (c)(1).
    (ii) [Reserved]
    (b) Specific requirements. The provisions of subpart A of this part 
apply to this section except as modified by this paragraph.
    (1) Recordkeeping. Recordkeeping requirements as specified in Sec.  
721.125 (a), (b), (c), and (k) are applicable to manufacturers, 
importers, and processors of this substance.
    (2) Limitations or revocation of certain notification requirements. 
The provisions of Sec.  721.185 apply to this section.

0
55. By adding new Sec.  721.10055 to subpart E to read as follows:


Sec.  721.10055  1-Propanaminium, 3-amino-N-(carboxymethyl)-N,N-
dimethyl-, N-soya acyl derivs., inner salts.

    (a) Chemical substance and significant new uses subject to 
reporting. (1) The chemical substance identified as 1-propanaminium, 3-
amino-N-(carboxymethyl)-N,N-dimethyl-, N-soya acyl derivs., inner salts 
(PMN P-03-46; CAS No. 136504-87-5) is subject to reporting under this 
section for the significant new uses described in paragraph (a)(2) of 
this section.

[[Page 14708]]

    (2) The significant new uses are:
    (i) Industrial, commercial, and consumer activities. Requirements 
as specified in Sec.  721.80(j).
    (ii) [Reserved]
    (b) Specific requirements. The provisions of subpart A of this part 
apply to this section except as modified by this paragraph.
    (1) Recordkeeping. Recordkeeping requirements as specified in Sec.  
721.125 (a), (b), (c), and (i) are applicable to manufacturers, 
importers, and processors of this substance.
    (2) Limitations or revocation of certain notification requirements. 
The provisions of Sec.  721.185 apply to this section.
    (3) Determining whether a specific use is subject to this section. 
The provisions of Sec.  721.1725(b)(1) apply to this section.

0
56. By adding new Sec.  721.10056 to subpart E to read as follows:


Sec.  721.10056  Benzenemethanaminium, N-(3-aminopropyl)-N,N-dimethyl-, 
N-soya acyl derivs., chlorides.

    (a) Chemical substance and significant new uses subject to 
reporting. (1) The chemical substance identified as 
benzenemethanaminium, N-(3-aminopropyl)-N,N-dimethyl-, N-soya acyl 
derivs., chlorides (PMN P-03-47; CAS No. 90194-13-1) is subject to 
reporting under this section for the significant new uses described in 
paragraph (a)(2) of this section.
    (2) The significant new uses are:
    (i) Industrial, commercial, and consumer activities. Requirements 
as specified in Sec.  721.80(j).
    (ii) [Reserved]
    (b) Specific requirements. The provisions of subpart A of this part 
apply to this section except as modified by this paragraph.
    (1) Recordkeeping. Recordkeeping requirements as specified in Sec.  
721.125 (a), (b), (c), and (i) are applicable to manufacturers, 
importers, and processors of this substance.
    (2) Limitations or revocation of certain notification requirements. 
The provisions of Sec.  721.185 apply to this section.
    (3) Determining whether a specific use is subject to this section. 
The provisions of Sec.  721.1725(b)(1) apply to this section.

[FR Doc. E7-5797 Filed 3-28-07; 8:45 am]
BILLING CODE 6560-50-S


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>